DD;;kk vvkkii vviiuuss ccssVVkk ;;kk ccssVVhh ddkkss MMkkWWDDVVjj ccuukkuukk ppkkggrrss ggSSaa\\nnss[[kkss ii`̀""BB llaa[[;;kk&&0066 iijj

Zydus Pharma Gets US FDANod For OCD Treatment Drug

Zydus Pharmaceuticals (USA) Ph:- +1609-7301900 has received final approval from the US health regulator tomarket Clomipramine Hydrochloride capsules, used to treat obsessivecompulsive disorder (OCD). The company has received final approvalfrom the US Food and Drug Administration (US FDA) to market thedrug in the strength of 25 mg, 50 mg and 75 mg, Zydus Cadila said ina BSE filing. The company will produce the drug at the group's formu-lations manufacturing facility at SEZ, Ahmedabad. Clomipramine

hydrochloride capsule is used to treat obsessive compulsive disorder,which is characterised by uncontrollable, re-occurring thoughts andbehaviours. The company has more than 180 approvals and so farfiled over 310 abbreviated new drug applications (ANDAs) since itcommenced filings in 2003-04. Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i

iiSSaaffØØ;;kkffVVffVVll ;;kk vvXXuukk''kk;;''kkkkssFFkk ddss ??kkjjssyyww mmiippkkjjiSafØ;kfVfVl ;kfu vXuk'k;'kksFk esa euq"; ds 'kjhj esa dqN jlk;fud ifjorZu rsth ls gksrs gSa] ftlls O;fÙkQ ds iQsaiQM+s çHkkfor gksrs gSa& bl nkSjku jÙkQ esa vkWDlhtu dk Lrj degks tkrk gS- dksf'kdkvksa esa balqfyu dk mRiknu gksus yxrk gS] O;fÙkQ dks 'kqxj Hkh gks tkrh gS] iQyLo:i vXuk'k;'kksFk ls O;fÙkQ xzflr gks tkrk gksrk gS- vXuk'k; esa ckj&ckj

laØe.k ls vXuk'k;'kksFk dk •rjk cuk jgrk gS- dbZ ckj ;g laØe.k xaHkhj Hkh gks tkrs gSa ftlls laØferÅrd fudkyus ds fy,vkWijs'ku Hkh djuk iM+ldrk gS- vXuk'k;'kksFkesa ,atkbe dk Lrj degksus yxrk gS tks fdgekjs }kjk •k;s x;s •kusdks ipkus ds ftEesnkjgksrs gSa& ,atkbe dh dehgksus ls otu ?kVus yxrkgS vkSj ywt eks'ku Hkh gksldrs gSa- ,sls esa 'kjhj esavYlj cuus yxrk gS-lcls •rjukd fLFkfrrc curh gS ;fn ;gvYlj vkarfjd jÙkQL=kkodjus yxs- vXuk'k;'kksFkls cpus ds fy, olkdh de ls de ek=kkvkgkj esa ysuh pkfg,rFkk pk;] dkWiQh vkSj'kjkc vkfn dk HkhbLrseky de ls dedjuk pkfg,- vkidksdqN ?kjsyw mik; crkrs gSaftUgsa le; jgsr viukdj vki 'kjhj dks vXuk'k;'kksFk ls cpk ldrs gSa- l nngghh%%&& ikpu ra=k esa larqyu dkscuk, j•us ds fy, ngh esa ekStwn thfor cSDVhfj;k dkiQh çHkko'kkyh gksrs gSa- ;g çfrj{kk ç.kkyh dks etcwr

cukus esa Hkh enn djrs gSa- l iikkyydd%%&& ikyd esa,aVhvkWDlhMsaV dh çpqj ek=kk gksrh gS tks fd çfrj{kk dksc

HHkkwwyyuuss ddhh cchheekkjjhh ddkkss ;;ss nnookk ggeess''kkkk ddss ffyy,, ••RRee ddjjssxxhhHkwyus dh chekjh vYtkbej ls eqdkcys dh fn'kk esa cM+h dke;kch feyh gS- tkikuh'kks/drkZvksa us bl chekjh ds bykt ds fy, ubZ nok fodflr dh gS- mudk nkok gS fdraf=kdk ra=k laca/h vYtkbej vkSj fMesaf'k;k tSls jksxksa ls futkr fey ldrh gS- vYtkbej

ds pyrs ;knnk'r ghugha cfYd efLr"ddh nwljh vge dk;Z{kerk,¡ Hkh fcxM+tkrh gSa- blds byktds fy, rksgksdw;wfuoflZVh ds'kks/drkZvksa us ubZ nok,l,ds3 fodflr dhgS- ;g nok ef"r"desa ,lsfVydksykbuL=kko dks çsfjr vkSjLe`fr dks csgrj djusdk dke djrh gS-

efLr"d esa ,lsfVydksykbu ,d rjg dk U;wjks VªkalehVj gS ftldh è;ku vkSj Le`fr esavge Hkwfedk gksrh gS- bl ç.kkyh ds lgh rjg dke ugha djus dh otg ls vYtkbejvkSj fMesaf'k;k tSls jksx gksrs gSa- ,l,ds3 ,feykW;M chVk çksVhu ds mRiknu dks Hkh jksdnsrh gS- ;g çksVhu bu jksxksa ds c

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i

Product ListMorksons Pharmaceuticals (India)

Pvt. Ltd.Morkcef-200 DT:- Cefixime 200 mg. (Alu-Alu) l MORKCEF-LB:- Cefixime 200 mg & Lactic Bacillius 60 million Spore D.T.(Alu-Alu) l MORKCEF-100 DT:- Cefixime 100 mg & LacticAcid Bacillius 60 million spore DT (Alu-Alu) l MORKCEF-O:-cefixime 200 mg & Ofloxacin 200 mg (Alu-Alu) l MORKCEF- OZ:- Cefixime 200 mgb & Ornidazole 500 mg (Alu-Alu) lMORKCEF-AZ :- Cefixime 200 mg & Azithromycin 250 mg(Alu-Alu) l MORKCEF-CX:- Cefixime 200 mg & Linezolid600 mg (Alu-Alu) l MORKCEF-CV:- Cefixime 200 mg &Potassium Clavulanate 125 mg (Alu-Alu) l CEFO- MORK-100 DT:- Cefpodoxime 100 mg (Alu-Alu) l CEFO-MORK-200DT:- Cefpodoxime 200 mg (Alu-Alu) l CEFOMORK-CV:-Cefpodoxime Proxetil 200 mg & Clavulanate Potassium 125mg (Alu-Alu) l CEFOMORK-AZ:- Cefpodoxime 200 mg &Azithromycin 250 mg (Alu-Alu) l CEFOMORK-O:-Cefpodoxime 200 mg & Ofloxacin 200 mg (Alu-Alu) l AZEE-FROTE:- Azithromycin 500 mg (Blister) l AZEE-MORK:-Azithromycin 250 mg (Blister) l MORKFLOX-200:- Ofloxacin200 ng (Alu-Alu) l MORKFLOX-100DT:- Oflozacin 100 mgDispersible Tablet (Alu-Alu) l MORKFLOX-N:- Ofloxacin 200mg & Nitazoxanide 500 mg (Alu-Alu) l MORKFLOX-OZ:-Ofloxacin 200 mg & Ornidazole 500 mg (Alu-Alu) l MORK-FLOX-400:- moxifloxacin 400 mg (Alu-Alu) l MOXWIN-CV625 :- Amoxycillin 500 mg & Potassium Clavinate 125 mg(Alu-Alu) l MOXWIN-250:- Amoxycilin Trihydrate 125 mgDispersible (Strip) l MOXWIN 500:- Amoxycillin Trihydrate500 mg (Strip) l MOXWIN-KID:- Amoxycillin Thihyrate 200mg & Potassium Clavinate 28.5 mg (Alu-Alu) l CIPRO-GRAN:- ciprofloxacin 500 mg (Alu-Alu) l CIPROGRAN-250:- Ciprofloxacin 250 mg (Alu-Alu) lCIPROGRAN-OZ:- Ciprofloxacin 500 mg &Ornidazole 500 mg (Alu-Alu) l CIPROGRAN-TZ:- Ciprofloxacin 250 mg & Tinidazole 300 mg(Alu-Alu) l LEVOFLOX-500 :- Levfloxacin 500mg (Alu-Alu) l LEVOFLOX-250 :- Levofloxacin250 mg (Alu-Alu) l LEVOFLOX-OZ:-Levofloxacin 250 mg & Ornidazole 500 mg (Alu-Alu) l CEFOMORK-LV :- Cefpodoxime 200 mg& Levofloxacin 250 mg (Alu-Alu) l CIPMAX-125DT :- Cephalexin 125 mg Dispersible (Strip) lCIPMAX-250 DT:- Cephalexin 250 mgDispersible (Strip) l M-NOR-TZ:- Norfloxacin400 mg & Tinidazole 600 mg (Alu-Alu) l CEFO-PRIME-CV:- Cefpodoxime 500mg & PotassiumClavulanate 125 mg (Alu-Alu) l CEFOPRIME-250:- Cefuroxime 250 mg 250 mg (Alu-Alu) lCEFOPRIME- 500 :- Cefuroxime 500 mgLevofloxacin l ARTHONIP-P:- Nimesuide100mg & Paracetamol 325 mg (Blister) lARTHONIP-MD:- Nimesulide 100mg (Blister) lV-FENCE PLUS:- Diclofenac Sodium 50 mg &Paracetamol 325 mg (Blister) l DECLONAC :-Diclofence Potassium 50 mg & Paracetamol 325mg (Blister) l ACEFLEX:- Aceclofenac 100 mg& Paracetamol 325 mg (Alu-Alu) l MORKFLEX:- Aceclofenac 100 mg & Paracetamol 325 mg(Blister) l ACEFLEX-MR:- Aceclofence 100 mg+ Paracetamol 325 & Chlozoxazone 250 mg(Alu-Alu) l MORKFLEX-MR :- Aceclofenac 100mg + Paracetamol 325 mg & Chlorzoxazone 250mg (Blister) l ACEMORK-SP:- Aceclofenac 100mg + Paracetamol 325 mg & Serratiopeptidase15 mg (Alu-Alu) l MORKFLEX-SP :-Aceclofence 100 mg + Paracetamol 325 mg &Serratiopeptidase 10 mg (Alu-Alu) l ARILOW-MR :-Diclofenac Potassium 50 mg + Paracetamol 325 mg &Chlozoxazone 250 mg (Blister) l ARILOW-SP:- DiclofencePotassium 50 mg + Paracetamol 325 mg & Serratiopetidase10 mg (Blister) l MORKFLEX-T:- Paracetamoil 325 mg &Tramadol Hcl 37.5 mg (Blister) l THIOWIST :- Paracetamol325 mg + Thiocolchiciside 4 mg & Aceclofenac 100 mg (Alu-Alu) l THIOWIS-AT:- Paracetamol 325 mg &Thiocolchicoside 4 mg (Blister) l TAKE-RELIFE:-Aceclofenac 100 mg + Paracetamol 325 mg &Tramdol 37.5mg (Alu-Alu) l TAKE-CARE:- Tramadol Hcl 37.5 mg +Dicofence Sodium 50 mg & Chlorzoxazone 250 mg (Alu-Alu)l LORI-CAME:- Lornoxicam 8 mg Paracetamol 325 mg (Alu-Alu) l ULTRACIN-500 :- Paracetamol 500 mg (Blister) lULTRACIN-650:- Paracetamol 650 mg (Blister) l ETO-PLUS:- Etoricoxib 90 mg (Alu-Alu) l ETO-MORK-P:-Etoricoxib 60 mg & Paracetamol 325 mg (Alu-Alu) lMORKPAR:- Dicyclomine Hcl 20 mg & Paracetamol 325 mg(Blister) l DOLFIN :- Ibuprofen 400 mg (Blister) l DOLFIM P:- Ibuprofen 400 mg & Paracetamol 325 mg (Blister) lMORK-COLD :- Levocetirizine 5 mg + Paracetamol 325 mg +Phenylephrine 5 mg & Ambroxol 30 mg (Blister) lCETRIZEN:- Cetirizen Hcl 10 mg (Blister) l ALECITZ :-Levocertirizine Hcl 5 mg (Alu-Alu) FEXODIN-120 :-Fexofenadine 120 mg (Alu-Alu) l FEX-MONT:-Fexofenadine 120 mg & Moutelukast 10 mg (Alu-Alu) lLEEMONT-LC :- Levocetirizine 5 mg & Montelukast 10 mg(Alu-Alu) l RELIEF-MORK:- Bromhexine 8 mg + DMR 10mg + CPM 2 mg & Guaiphensin 100 mg (Blister) l PYRI-CAM:- Piroxicam Dispersible 20 mg (Alu-Alu) l ALVERTZ :-Cinnarizine 25 mg (Alu-Alu) l ALVERTZ-D :- Cinnarizine 25mg & Domperidone 5 mg (Alu-Alu) l DOTAWIN:-Drotaverine 80 mg & Mefenamic Acid 250 mg (Alu-Alu) lTRMA-MORK:- Tranexamic Acid 500 mg & Mefenamic Acid250 mg (Alu-Alu) l REXO-X :- Roxithromycin 150 mg &

Ambroxol Hydrochloride 60 mg (Alu-Alu) l ETOLIV-P :-Etodolac 400 mg & Paracetamol 325 mfg (Alu-Alu) lETROWIN :- ETAMSYLATE 250 mg (Alu-Alu) lMORKSPAS:- Mefenamic Acid 250 mg & Dicyclomine 10 mg(Blister) l DEXAWIN :- Dexamethasone 0.5 mg (Strip) lBETAWIN:- Betamethasone 0.5 mg (Strip) l D-CORT-6 :-Deflazacort 6 mg (Alu-Alu) l ACEPRIDE-4 :- MethylPrednisolone 4 mg (Alu-Alu) l Acepride-8:- MethylPrednisolone 8 mg (Alu-Alu) l ACEPRIDE-16:- MethlyPrednisolone 16 mg (Alu-Alu) l PREDIMORK:- Prenisolone5 mg (Blister) l PREDIMORK:- Prenisone 10 mg (Blister) lPLEASURE-150:- Slidenafil Citrate 150mg (Blister) l PLEA-SURE-100 :- Slidenafil Citrate 100 mg (Blister) l PLEA-SURE-50 :- Sildenafil Citrate 50 mg (Blister) l PLEASUREEXTRA:- Depoxetine 30 mg & Slidenafil citrate 50 mg(Blister) l PLEASURE-F:- Tadalafil 20 mg (Blister) lTWIST-30:- Dapozetine 30 mg (Blister) l TWIST-60 :-Dapoxetine 60 mg (Blister) l PLEASURE-KIT :- Misoprostol200 mcg & Mifepristone 200 mg (Alu-Alu) TUCH :-LeLevonorgestrel 1.5 mg (Blister) l FLUCOMED-150:-Fluconazole 150 mg(Blister) l TERBINA-250:- TerbinafineHcl 250 mg (Blister) l MORKPENT 40 :- Pentoprazole 40 mg(Alu-Alu) l MORKPENT-D:- Petoprazole 40 mg &Domperidome 10 mg (Alu-Alu) l RABIZOLE-20 :-Rabeprazole 20 mg (Alu-Alu) l RABIZOLE-D:- Rabeprazole20 mg & Domperidome 10 mg (Alu-Alu) l RANTILOC-150:- Rantidine Hcl 150 mg (Strip) l RANTILOC-D :- RantidineHcl 150 mg & Domperidome 10 mg (Strip) l CYPOWIN-4:-Cyproheptadine Hcl 4 mg (Blister) l VOMIMORK-MD:-Ondansetron 4 mg Mouth Dissolving (Blister) l

DOXYMORK-P:- Doxylamine Succinate 10 mg + Pyridoxine10 mg & Folic Acid 2.5 mg (Alu-Alu) l GROW-24:- SodiumFeredatate 231 mg + Folic Acid 1.5 mg & Vitamin B12 15 mcg(Alu-Alu) l GROW-PLUS :- Ferrous Ascorbate 100 mg +folic ACid 1.5 mg & Zinc sulphate 22.5 mg (Alu-Alu) l LEED-5 :- folic Acid 5 mg (BLISTER) l CALCI-MORK :- Calciumcarbonate 1250 & Vitamin D3 250 iu (Blister) l MORKWIN-500 :- Methylcoblamin 500 mcg (Stripi) l MORKWIN 1500 :-Methycoblamin 1500 mcg (Strip) l SPORT :- Metylcoblamin1500 mcg + Alpha Lipoi Acid 100 mg + Folic Acid 1.5 mg &Thiamine Hcl 10 mg (Alu-Alu) l BENDIMORK :- aLbensazole400 mg (Alu-Alu) l AB-ZOLE-IV:- Albendazole 400 mg &lvermectin 12 mg (Blister) l ITRARAB-DSR :- Raberprazole20 mg & Itopride Hydrochloride 150 mg (sustained Release)(Alu-Alu) l TRAMAPAIN :- Tramadol 50 mg (Blister) lMORKWIN-PLUS:- Methylcobalamin 1500 mcg + AlphaLipoic Acid 100 mg + Folic Acid 1.5 mg + Thiamine 10 mg &Pyridoxine Hcl 3 mg (Alu-Alu) l PREGALIN :- Tramadol50mg + Pregabalin 75mg + Mecobalawin 1500 mcg + AlphaLipoic Acid 200 mg + Folic Acid 2.5 mg & Vit B6 5 mg (Alu-Alu) B-COMPLEX :- B- Complex + Vitamins with ZincSulphate (Strip) l MORK-DINE :- Povidone-lodine 5% w/w(Lemi tube) l MORK-DINE :- Povidone Iodine 5% w/w (JAR)BECLO-SONC-NC :- Beclomethasome Dipropionate 0.025%w/w + Neomyclin 0.5% w/w & Clotrimazole 1% w/w (Lemitube) l AVERCLEAN :- Clindamycin 1% w/w & Nicotinamide4% w/w (Lemi tube) l CLOVIT-S :- clobetasol Propionate0.05% w/w & Salicylic Acid 3.0% w/w Salicylic Acid 3.0% w/w(Lemi Tube) l ULTRA-PEARL :- Hydroquinone 2% +Tratinoin 0.025% + Mometosone Furoate 0.01% (Lemi tube) Mob:- 09720028383, 09720028585.

E-Derma PHARMA INDIA PVT. LTD.Antibiotics:- AZICA Tab. (Azithromycin 250/500mg) AUGFAST Cap. (Amoxycillin Trih 500mg, Potassium Clav.

125mg.) CEFITURN capsule (Cephalexin 500 mg) DAllOX(Amoxycillin 250mg & Dicloxacillin 250mg) MINOPEARL Tab.(Minocycline 50/100mg) DYNACLIN Cap. (Clindamycin150/300 mg ) FUDICA Cr. (Fusidic acid 2%) FUDICA B Cr. (Fusidic acid 2% & Beclo. Prop.) l Antiallergic:- E-BESTTab. (Mizolastine 10 mg) HYBEST Tab. (Hydroxyzine 10/25mg) LORAID Tab. (Loratadine 10 mg) LEVOCA Tab./Syp(Levocetirizine 5 mg) POLBEST Tab. (Dexchlorpheniramine2mg) FEX UP Tab. (Fexofenadine 180 mg) (CALOMYNE Lot.Calamine 15%, Phenol 0.5%, Zinc Oxide 5%, Bentonite 3% &Menthol) l Steroids:-DYNACORT Tab. (Deflazacort 6/12/30mg) SAFECORT Lot/Cr. (Mometasone Furoate 0.1%) ECZI-VATE Cr. (Clobetasol Prop. 0.05%) HALOTURN Cr.(Halobetasol Prop. 0.05%) FLUTURN H Cr. (FluocinoloneAcetonide 0.1%) NADIREST M Cr. (Nadifloxacin 1% &Mometasone 0.1%) NADIREST Cr. (Nadifloxacin 1%) DESO-CARE Lot. (Micronised Desonide 0.05%) ECZIVATE-S Lot.(Clobetasol 0.05% & Salicylic Acid 3% /6%) ISORVATE ALGel (Clobetasol prop. 0.05% & Ammonium phosphate 12%)l Antifungal:- ITRASTAT Cap. (Itraconazole 100 /200 mg)TERBAZ Tab./Cr./Dust. Pow. (Terbinafine 250 mg) KTZTab./Cr./Dust. Pow. (Ketoconazole 200 mg) FLUPACK Tab.(Fluconazole 150 mg) CANBEE Cr. (Clotrimazole 1%) CAN-BEE-B Cr. (Clotrimazole 1% ,Beclomethasone 0.025%)SERTAFIX Cr. (Sertaconazole 2.0% ) K-WASH Shampoo.(Ketoconazole 2%) K-WASH PLUS Shampoo.(Ketoconazole 2% & ZPTO 1%) l Immunosuppressants:-AZONY Tab. (Azathioprine 50 mg) TACROGARD 0.1 Oint.(Tacrolimus 0.1/.03%) SORAPRIN Softgel Cap.(Cyclosporine 100mg) NEOTURN Tab. (Methotrexate2.5/5/7.5 mg) l Acne Care:-ISOPEARL M 20 Softgel Cap.(Micronised Isotretinoin 20mg) ISOPEARL Softgel Cap.(Isotretinoin 10/20mg) DYNACLIN-N Gel Clindamycin 1% &

Nicotinamide 4%) DYNACLIN Gel (Clindamycin1%) O-GYL Gel. (Ornidazole 10 mg) ADAQUE-EN Gel (Adapalene 0.01%) ADAQUEEN -C Gel(Adapalene 0.01% & Clindamycin 1%) BENZI-TURN-AD Gel (Adapalene 0.1%, Benzoyl per-oxide 2.5%) TRET-A Cr. (Tretinoin 0.025%) lHypopigmenting Agents:- AZESPOT Cr.(Azelaic acid 15% ) FACELITE Cr. (Kojic Acid2%, Arbutin 1.5%, Octinoxate 7.5%, MulberryExtract & Glycolic Acid) M-LITE Cr.(Hydroquinone 2%, Oxybenzone 2.5% &Octinoxate 7.5%) M-LITE PLUS Cr.(Hydroquinone 2% & Tretinoin 0.025%) M-LITEFORTE Cr. (Hydroquinone 2%, Tretinoin0.025% & Mometasone 0.1%) M LITE GLOW Cr.(Hydroquinone 2%,Tretinoin0.025% &Fluocinolone Acitonide 0.01%) GLOW DAY Cr.(Glycolic acid, Alpha Arbutin, Tocopheryl acetate,Resorcinol, Titanium Dioxide) GLOW NIGHT Cr.(Alpha Arbutin, Retinol, Liquorice, Vit. E,Glycerine Squalene, D- alpha Tocopherol,Lenolin) GLUTAGLOW Tab. (Glutathione500mg and Lipoic acid 200mg) GLUTAGLOW -C Tab. (Glutathione 500mg and Lipoic acid200mg, Vitamin C 1gm) l Antioxidants/Vitamins:- LYCOXID Tab. (Betacarotene (10%)30 mg., Lycopene (10%) 7500 mcg., Vit. C 150mg., Vit. E 25 mg., Minerals & Zeaxanthine(10%) 25 mg) PROCDINA TX Tablet(Tranexamic acid 250 mg) PROCDINA Tab.(Proanthocyanidin 75 mg) IRONI UP Cap.(Carbonyl Iron 100 mg, Vit. C 150 mg., Vit. B1215 mcg., Folic Acid 5 mg., Zinc Sulphate 61.8mg. & Vit B6 3 mg) l Hair Care:- FINTURNTab. (Finasteride 1 mg.) BIOTURN FORTE Tab.(Biotin 10 mg., Calcium Pantothenate 100 mg.,N-Acetyl Cysteine 50 mg. & Minerals)

MINTURN-XL Lot. (Minoxidil 5% & Aminexil 1.5%) MINTURNLot. (Minoxidil 2/5/10%) HAIR LONG Oil (Olive Oil, AmlaExtract, Sun flower Oil, Castor Oil, & Grapeseed Oil) HAIRLONG Tab. (Saw palmetto powder 160mg, Green tea 50mg,ginkgo biloba 10mg,Nettle leaf extract 50mg, amino acid,Vitamin B6 3mg, Collagen peptide 50mg & minerals) HAIRLONG Ser. (Anagain, Procapil ( Oleanolic acid, ApigeninBiotinoyl Tripeptide-1 ) Polyquart -7) Hair Long B+ Oil (Biotin,saw palmetto, D -panthenol, Sugandha Kokila Seasame oil,roots of karondy,) SOFTUM Shampoo (Shea Butter,Ceramides,Soya protein) l Soap/ Facewash:- E-BACTYSoap. (Triclosan, Allantoin & Alum) ACNE DAY Soap(Triclosan, Triclocarben, Glycerin, Vit. E Aloe Vera & Tree TeaOil) KTZ Soap (Ketoconazole 2%) SCABICA Soap(Permethrin, Aloe Vera & Tree Tea Oil) BEAUTY Bar (Aloevera, Milk protein, Shea butter, Cocoa butter, Titanium diox-ide, Almond oil, Tea tree oil, Vit E.) SOFTUM BABY Bar pH5.5 (Syndet Base, Shea Butter, Aloe Butter, 4,4- DistyrylBiphenyl Dertivative, Pentaerythrityl Tetra-di-t-ButylHydroxyhydrocinnamate and Perfume) SOFTUMMoisturizing Bar pH 5.5 (Syndet Base, Shea Butter, AloeButter, 4,4- Distyryl Biphenyl Dertivative, PentaerythritylTetra-di-t-Butyl Hydroxyhydrocinnamate and Perfume) VISIASoap (Aloe Vera, Vit. E & Moisturising) VISIA Face Wash(Lemon, Honey, Menthol, Mulberry Extracts) ACNE DAYFace wash (D panthenol, Aloe vera, Vit E, Triclosan, Salicylicacid, Allantoin & Witch Hazel) l Emollients:- VISIA Cr./LotGlycerine 6.0%, Tocopheryl Acetate 0.5%, Liquid Paraffin10.0%, Cetyl Alcohol 3.0%, Squalene & Aloe Vera) Visia SoftCr. (Propylene Glycol, Emulsifyng wax, Glycerine,Cyclomethicone, Zinc Oxide) Visia Lip Balm (Paraffinwax,Dimethicone with sunscreen) l Sunscreen:- O' BAYSPF 30 (Octylmethoxycinnamate 5.0%, Avobenzone 2.0%,Methoxy Cinnamidopropyl Hydroxy Sultaine 2.0%, ZincOxide 2.0%, Allantion 0.2%, Vitamin E 0.1%, Aloe Vera Gel0.2% & Phenoxyethanol 1.0%) VISIA SPF 50 (Octinoxate7.5% ,Avobenzone 2%, Oxybenzone 3%,Octocrylene 3%,ZnO 2%, Titanium dioxide) Ph :- 9034435000, 9034635000.

CablinTABLET SECTION:- ALLERSONE (Betamethasone SodiumPhosphate 0.5 mg) ll ALPHA CALCIN (Calcium Carbonate625mg + Alphacalcidol 0.25mcg + Betacarotene 2500 I.U) llCABCIN 250 (Ciprofloxacin 250 mg) ll CABCIN 500(Ciprofloxacin 500 mg) ll CABIMAX CV (Amoxycillin 500mg+ Clavulanic Acid 125 mg) ll CABIMAX-250 (Amoxycillin250 mg) ll CABLIDE (Nimesulide 100 mg) ll CABLIDE MD(Nimesulide 100 mg (Mouth Dissolving Tab) ll CABLIDE P(Nimesulide 100 mg + Paracetamol 325mg) ll CABLIDE-COLD (Nimesulide 100mg + Paracetamol 325mg +Phenylephrine 5mg + Cetrizine 5mg + Caffeine30mg) llCABLOX 100 (Ofloxacin 100mg) ll CABLOX 200 (Ofloxacin200mg) ll CABLOX 400 (Ofloxacin 400 mg) ll CABLOX OZ(Ofloxacin 200 mg + Ornidazole 500 mg) ll CABNAC(Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg) llCABNAC SP (Diclofenac potassium 50mg +Serratiopeptidase 10mg + Paracetamol 325mg) ll CABOLIV250 (Levofloxacin 250 mg) ll CABOLIV 500 (Levofloxacin500 mg) ll CABOLIV 750 (Levofloxacin 750 mg) ll CAB-ROLE-20 (Rabeprazole 20 mg) ll CABROLE-D(Rabeprazole 20 mg + Domperidone 10 mg) ll CADINASE(Diclofenac Sodium 50mg + Paracetamol 325 mg) ll CADI-NASE MR (Diclofenac Sodium 50mg +Paracetamol 325mg +Chlorzoxazone 250mg) ll CALBIZOLE (Albendazole 400 mg+ Ivermectin 6 mg) ll CALCIN-CT (Calcium Citrate 1200 mg+Calcitrol 0.25 mcg+ Magnesium Hydroxide 100 mg+Zinc 22.5mg) ll CALCIN-D (Calcium Carbonate 1250 mg+ Vitamin D3250 IU+ L-Lysine 50mg+ Magnesium 100mg) ll CALCOL-ZF(Calcium Citrate Malate, zinc and folic acid &vit D) llCEFOLIN (Cefixime 200 mg) ll CEFOLIN-AZ (Cefixime 200mg + Azithromycin 250 mg) ll CEFOLIN-DC (Cefixime 200mg + Dicloxacillin 250 mg) ll CEFOLIN-O (Cefixime 200 mg+ Ofloxacin 200 mg + Lactic Acid Bacillus 60million spores) llCOZIMAX 250 (Azithromycin 250 mg) ll COZIMAX 500(Azithromycin 500 mg) ll DICET M (Dicyclomine HCL 20mg+Mefanemic acid 250 mg) ll DICET P (Dicyclomine HCL20 mg + Paracetamol 325 mg) ll D-TRON (Ondansetron 4mg) ll F CORT-6 (Deflazacourt 6 mg) ll FERTIM-500(Cefuroxime 500 mg) ll FEXMON (Fexofenadine 120 mg +Montelukast 10 mg) ll FLUCAB-150 (Flucanazole 150 mg) llH-FER (Ferrous Ascorbate 100mg + FA 5mg +Cyanocobalamin 15mcg + Cholecalciferol 1000IU + Zinc 22.5mg) ll KABADOL (Taramadol 100 mg + Paracetamol 325mg) ll LECIT (Levocetirizine 5 mg) ll LECIT-AM(Levocetrizine 5 mg + Ambroxol Hydrochloride 60 mg) llLECIT-M (Levocetrizine 5 mg+ Montelukast 10 mg) llLENAC-D (Aceclofenac 100 mg + Drotaverine 80 mg) llLENAC-MR (Aceclofenac 100 mg+ Paracetamol 325 mg+Chlorzoxazone 250 mg) ll LENAC-P (Aceclofenac 100 mg+Paracetamol 325 mg) ll LENAC-SP (Aceclofenac 100 mg +Paracetamol 325 mg +serratiopeptidase 15 mg) ll LINCOX-IB (Etoricoxib 120 mg) ll LINPAR 650 (Paracetamol 650 mg)ll LINPAR COLD (Paracetamol 325mg + Phenylephrine 5 mg+ Cetirizine 5 mg) ll LUMARTIN (Artemether 80mg +Lumfantrine 480mg) ll MECOLIN (Methycobalamin 1500mcg) ll MEFERINE D (Drotaverine 80 mg + Mefenamic Acid250 mg) ll OMIDON-MD (Domperidon 10 mg (MouthDissolving) ll PANTLIN 40 (Pantoprazole 40 mg) ll PANTLIND (Pantoparazole 40 mg + Domperidone 10 mg) ll SEFROL-D3 (Cholecalciferol 60000 I.U.) VITALIN (Ginseng 42.5mg+Vit. A 2500 I.U+Vit D3 200 I.U+ Thiamine HCL 2 mg+Riboflabin 3 mg+Pyridoxine 1.5mg+Cyanocobalamin 0.5mcg+Niacinamide 25 mg+folic acid 300 mcg+CopperSulphate 2 mcg+Potassium lodide100mcg+Magnesium sul-phate 3 mg+Zinc sulphate monohydrate 10mg) ll ZEPOD100 (Cefpodoxime 100 mg) ll ZEPOD 200 (Cefpodoxime 200mg) ll ZITHROLIN (Roxithromycin 150 mg) CAPSULE SEC-TION:- CABIMAX-500 (Amoxycillin 500 mg) ll CABROLEDSR (Rabeprazole 20 mg + Domperidone 30 mg (SR) llCABROLE-L (Rabeprazole 20 mg + Levosulpiride 75 mg) llFECOLIC (Ferrous Fumerate 300 + Vitamin B 12 15 mcg+Folic Acid 1.5 mg) ll ITRACAB-100 (Itraconazole 100 mg) llITRACAB-200 (Itraconazole 200 mg) ll MECOLIN GOLD(Methylcobalamin 1500 mcg + Alpha Liopic Acid 100 mg+Vitamin B6 1.5 mg+ Folic Acid 1.5 mg) ll MECOLIN-P(Pregabalin 75 mg + Methylcobalamin 750 mcg) ll OMPREC-20 (Omeprazole 20 mg) ll OMPREC-D (Omeprazole 20 mg+ Domperidome 10 mg) ll PANTLIN DSR (Pantoprazole 40mg + Domperidone SR 30 mg) ll PRO-BIOLIN (Pre- ProBiotic capsule for healthy gut) ll SOMIPRAC DSR(Esomeprazole 40 mg + Domperidone 30 mg) ll VIBROLIN(Carbonyl Iron 100 mg+ FA 1 mg + Cyanocobalamin 5 mcg +Vitamin B12 5 mcg+ Vitamin E 15 mg + Selenium 65 mcg +Zinc 22.5 mg) VITALIN (Lycopene 5000 mcg + Selenium 100mcg + Thiamine) ll VITAMORE (Antioxidant, Multivitamin &Mineral Supplement Capsule.) LIQUID ORALS SECTION:-BRONEX (Terbutaline 1.25 mg + Bromhexine 4 mg +Guaiphenesin 50 mg + menthol 0.5 mg) ll BRONEX(Terbutaline 1.25 mg + Bromhexine 4 mg + Guaiphenesin 50mg + menthol 0.5 mg) ll BRONEX-A (Terbutaline 1.25 mg +Ambroxol HCL 15 mg + Guaiphenesin 50 mg + Menthol 0.5mg) ll CABIFER-G (Ferrous Gluconate 129.5 mg + Folic Acid0.25 mg + Calcium Lactate 75 mg + Vit B12 1.25 mcg) llCABIFER-Z (Carbonyl Iron 100 mg + FA 1 mg +Cyanocobalamin 5 mcg + Selenium 30 mcg + Zinc 22.5 mg)ll CABLOX-50 (Ofloxacin USP 50 mg) ll CALCIN D3(Calcium Lactate 200 mg + Calcium Gluconate 125 mg withVitamin D3 200IU) ll CEFOLIN Dry Syrup (Cefexime 50 mg)ll CEFOLIN O Dry Syrup (Cefexime 50 mg + Ofloxacin 50mg) ll COMETHAZIN (Promethazine HCL 5 mg) ll COMET-HAZIN (Promethazine HCL 5 mg) ll COZYDRYL(Diphenhydramine HCL 14.08 mg + Ammonium Chloride 138

mg + Sodium Citrate 57.03 mg + Menthol 0.91 mg) ll CUF-FLIN (Dextromethorphan Hydrobromide 10 mg +Phenylephrine HCL 5mg + CPM 2 mg) ll CUFFREST-LS(Ambroxol 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1mg) ll CUFFREST-LS (Ambroxol 30 mg + Guaiphenesin 50mg + Levosalbutamol 1 mg) ll DIPSIN (Diastase 50 mg +Pepsin 10 mg) ll DIPSIN SUGARFREE (Diastase 50 mg +Pepsin 10 mg (SUGAR FREE) ll D-TRON (Ondansetron 2mg) ll FECOTOL (Ferric Ammonium Citrate 160 mg + FolicAcid 0.5 mg+ Cyanocobalamin 7.5 mcg + Sorbitol 70%Solution 10% w/v) GELLY-M (Magaldrate 400 mg +Simethicone 20 mg) ll GELLY-O (Magnesium Hydroxide 98mg + Hydroxidege 0.192 mg + Oxtetacaine 10mg) ll H-FER(Ferrous Ascorbate 30 mg + FA 1.5mg + Methylcobalamin 10mcg + Zinc 11.5 mg) LECIT (Levocetrizine 5 mg) ll LECIT-M(Levocetrizine 2.5 mg + Montelukast 4 mg) ll LINPAR(Paracetamol 250 mg/5ml) LINPAR COLD (Phenylephrine2.5 mg+ Paracetamol125 mg+ Chlorphiramine Melate 1 mg)ll LINPAR PLUS (Phenylephrine HCL 5 mg +Chlorpheniramine Maleate 2 mg + Sodium Citrate 60 mg +Paracetamol 250 mg + Menthol 1 mg) ll LINPAR-M(Mefenamic Acid 50 mg +Paracetamol 125 mg) ll LUCRATE(Sucralfate 1000 mg / 10 ml.) ll LUCRATE-O (Sucralfate 1000mg + Oxetacaine 20 mg / 10 ml.) ll TERBITOL (TricholineCitrate275 mg + Sorbitol 70% w/v) ll TERBITOL-H(Cyproheptadine 2 mg +Tricholine Citrate 275 mg + Sorbitol70% w/v) ll VITALIN (Lycopene 2500 mcg+ Vitamin A 1600IU + Cholecalciferol 200 IU+Vitamin E 7.5 IU+ Thiamine HCl.2 mg + Riboflavin Sodium + Phosphate 2.5 mg + PyridoxineHCl. 1.5 mg + Cyanocobalamin 1 mcg + D- Panthenol 1.5 mg+ L-Lysine HCl. 15 mg) ll VITALIN SUGAR FREE (Lycopene2500 mcg+ Vitamin A 1600 IU + Cholecalciferol 200IU+Vitamin E 7.5 IU+ Thiamine HCl. 2 mg + RiboflavinSodium + Phosphate 2.5 mg + Pyridoxine HCl. 1.5 mg +Cyanocobalamin 1 mcg + D- Panthenol 1.5 mg + L-LysineHCl. 15 mg) ll ZEPOD-100 (Cefpodoxime 100 mg) llZEPOD-50 (Cefpodoxime 50 mg) INJECTABLES SECTION:-ALPHACATH (Alpha-Beta-Arteether 150 mg) ll CABIMAX-CV (Amoxycillin 1000 mg + Clavulanic Acid 200 mg) ll CAB-INEM (Meropenem 1 gm) ll CABINEM-S (Meropenem 1 gm+ Sulbactum 500 mg) ll CABNAC (Diclofenac Sodium75mg/ml) ll CABPIME (Cefipime 500 mg) ll CEFTRON-1000(Ceftriaxone 1000 mg) ll CEFTRON-250 (Ceftriaxone 250mg) ll CEFTRON-500 (Ceftriaxone 500 mg) ll CEFTRON-750 (Ceftriaxone 500 mg + Sulbactum 250 mg) ll CEFTRON-S 1500 (Ceftriaxone 1000 mg + Sulbactum 500 mg) llKYCIN-500 (Amikacin 500 mg) ll MECOLIN-1500(Methycobalamin 1500 mcg/2 ml) ll MECOLIN-2500(Methycobalamin 2500 mcg/2 ml) ll MECOLIN-GOLD(Methycobalamin 1000 mcg/2 ml +Pyridoxine Hydrochloride100mg + Niacinamide 100mg) ll PANTLIN (Pantoprazole 40mg (Lypholised) ll PEPLIN-T (Piperacillin 4 gm +Tazobactam 500 mg) ll RENATE-25 (NandroloneDeconate25 mg) ll RENATE-50 (NandroloneDeconate 50 mg) PEDIATRIC:- COZIMAX-KID (Azithromycin 100 mg / 5 ml.) llCUFFREST-LS (Ambroxol 7.5 mg + Guaiphenesin 12.5 mg +Levosalbutamol 0.25 mg) ll DICET-KID (Dicyclomine 10 mg+ Simethicone 40 mg / ml.) ll DIPSIN-KID (Diastase 33.33mg + Pepsin 5 mg/ml) ll LINPAR KID (Paracetamol 125 mg/ 1ml.) ll LINPAR-COLD KID (Phenylephrine 12.5 mg +Chlorpheniramine 2 mg + Paracetamol 125 mg/ml.) ll VITAL-IN KID (Lycopene 2500 mcg+ Vitamin A 1600 IU +Cholecalciferol 200 IU+Vitamin E 7.5 IU+ Thiamine HCl 2 mg+ Riboflavin sodiumPhosphate 2.5 mg +Pyridoxine HCl. 1.5 mg +Cyanocobalamin1 mcg +D- Panthenol 1.5 mg + L-Lysine HCl 15 mg perml.) NUTRITIONAL SUPPLEMENT:- PROMEC-C(Protein Powder with Mecobalamin ChocolateFlavour) ll PROMEC-SF (Protein Powder withMecobalamin Chocolate Flavour (SUGAR FREE)SOFTGEL SECTION:- CABLIUM K2 7 (VitaminK2 7 ( Under Drug Not in Food ) ll VITALIN-4G(Ginko Biloba 9 (Under Drug Not in Food )AYURVEDIC PRODUCT:- ALIV (Herbal LeverTonic) ll MENSTROVEN (Ayuvedic Uterine Tonicfor woman) ll PAINGONE (Ayurvedic Pain KillerOil) EYE/EAR DROPS:- CABLOX-EYE (Ofloxacin0.30%w/v + & Hydroxypropyl Methyl cellulose0.25%w/v) ll EARLIN (Clotrimazole +Betamethasone + Lignocaine & Oflaxacin)SACHETS:- SEFROL-D3 (Cholecalciferol 60,000IU (SACHET) ll PRO-BIOLIN (Pre- Pro Bioticgranules for healthy gut (SACHET) OINTMENTSSECTION:- CABNAC-GEL (DiclofenacDiethylamine dp1.16% +Diclofenac sodium 1.0% +Linseedoil BP 3% + Methyl Salicsiyate 10% +Menthol 5% + Benzylalchollic)

Mob:- 9803672858, 09897392559.

Virgo Healthcare Pvt.Ltd.BIOLAX Syrup 100/200 ml (Lactitol Monohydrate)ll BIOVIR Sachets / Capsules (Prebiotic &Probiotic) ll FEROVIR Tablet/Syrup (SodiumFeredetate + Folic Acid + Vit. B12 + Zinc) ll PRO-TIVIR 200gm Powder (Micronutrient-enrichedProtein Chocolate / Elaichi Flavour) ll PANTOVIRTablets (Pantoprazole 40mg) ll PANTOVIR-DTablets (Pantoprazole 40mg + Domperidone10mg) ll RABIVIR Tablets (Rabeprazole 20mgEnteric Coated) ll RABIVIR-DSR Capsules(Rabeproazole with Sustained ReleaseDomperidone) ll LYCOVIR Capsules/Syrup(Lycopene, Alpha Lipoic Acid with Multivitamin &Multimineral) ll DROTIVIR-M Tablets (Drotaverine

80mg + Mefenamic Acid 250mg) ll VIZYME Syrup (FungalDiastase, Pepsin & Vitamin B-Factors) ll TRILAX Powder(Gum Karaya 47.3gm + Lactitol 40.0gm + Senna 0.70 gm /100gm) ll FLUCOVIR Tablets (Fluconazole 150 mg) ll V D3Sachet / MD Tablets (Cholecalciferol Vitamin D3 60,000 I.U.)ll Vital-5 Tablets (DHA, Biotin, Methylcobalamin, Pyridoxal 5Phosphate L-Methylfolate Calcium) ll Neurovir-ODCapsules (Methylcobalamin 1500 mcg + Alpha lipoic Acid200 mg + Ascorbic Acid 100 mg + Vitamin A 2500 I.U. +Pyridoxine 3 mg Selenium 100 mcg + Vitamin E 25 I.U. + FolicAcid 1.5mg + Zinc Sulphate 30mg ll Neurovir-PG Capsules(Methylcobalamin 750 mcg + Pregabalin 75 mg )

Mob:- 09212189650.

Puremed BiotechACYHERP-400 TAB Acyclovir 400 Mg l ALLERSKIN-25TAB Hydroxizine 25Mg l DERMIPRED- 4 TABMethylprednisolone IP 4mg l DERMICON-150 TABFiuconazole 150 Mg l DERMICON-400 TAB. Fluconazole400 Mg l DERMIDEF-6 TAB Deflazacort 6 Mg l FEXEE-120 TAB Fexofenadine 120 Mg l FEXEE-180 TABFexofenadine 180 Mg l NULOR-MD-10 TAB Loratidine 10Mg-Md l SKINCET- 5 TAB Levocetirizne 5MG. l TER-BIPURE - 250 TAB Terbinafine 250mg l WORMFREE TABAlbendazole 400, Ivermectin 6 l AZISKIN 500 TABAzithromycin 500mg l EBAHIST-10 TAB Ebastatine-10mg lVITAL-S.H.N . TAB Biotin 5mg., N-Acetyl cyst 50mg.Calcium pan 100mg Sodium selenite 65mg, Cupric oxide3mg, Zinc oxide 22.5mg l HAIR HEALTH TAB Biotin10mg.+ vitamin c 40mg. + folic acid 150 mg. calcium panto.5 mg. l KETSKIN-200 TAB Ketoconazole 200mg. lSKILOR-5 TAB Desloratidine 5 Mg l SKINCET-M TABLivecetrizine 5 Mg Monticlukast 10 Mg l TERBIPURE-ITTAB Terbenafine 250mg, Itraconazole 100 Mg l ACCUDOX-LB 100 CAP DOXYCILINE 100MG + LB 5 l LYSKIN SOFT-GEL CAP. Lycopine+Multivitamin+Antioxidant l TRETSKIN-20 SOFT GEL CAP. ISOtretinoin 20 mg l ITCON-100 CAPItraconazole-100 l ITCON-200 CAP Itraconazole-200 lACNERITE-AD CREAN Clindamycin 1% Adaplene 0.1%l ACNERITE-N CREAM Clindamycin 1% Nicotinamide 4%l DERMISOL -MN CREAM Clobetasole 0.05% Neomycin0.5% Miconazole 2% l DERMISOL-S CREAM Clobetasole0.05% Salisalic Acid 3% l DERMISOL CREAM CLOBETA-SOL 0.5% l KETSKIN OINT Ketokonazole 2% l LULETOPCREAM Luliconazole 1% l SKIN RITE CREAM Ofloxacin IP0.75% w/w, Orindazole IP 2.0%w/w,Terbinafine 1.00%w/w,Clobetasol Pro. 0.05%w/w l TERBIPURE CREAMTerbinafine 1% l KETSKIN SOAP Ketoconazole-1% ZPTO-1% + Aloevera 2% Glycerin 3% l PERMICET SOAPPermithrin -1% Glycerin l ACNERITE SOAP Triclosan-0.05, Tea Tree Oil, Zinc Oxide - 0.05%, Vit-E Ip-0.25,Allantoin Bp 0.25 l SKINRITE SOAP Aloe Vera-4% Vit-E-0.5% Glycerin-2% l CETRIBECT SOAP CETRIMIDE 0.5 %GLYCERINE l CALSKIN LOTION Calamine 8.0% Lightliquid paraffin 10.0% l KETSKIN LOTION Ketoconazole2.0% Zinc pyrithione 1.0% l SALEE-CT LOTION SalisalicAcid 3% Coltar Sol 1% l SCABILON LOTION GamaBenzine 1% Cetrimide 0.1% l PERMICET LOTIONPermithrin 5% l PUREKLEEN CLEASNING LOTION CetylAlcohal 2.65% Stery Alcohal 0.26% l CEEZOLE POWDERClotrimazole 1% Mob:- 09736701313, 09882011313.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i

Forth Coming EventsJanuary 15-17, 2018 IME 2018 (Muscat, Sultanate ofOman.) The forst edition of International Medical Expo 2018,Medical equipment and products exhibition is scheduled to beheld at Oman Convention and Exhibition Centre in Muscat,Sultanate of Oman. For details contact: the Top organizingexhibition and Convention, PO Box: 282, P.c: 130, Muscat,Sultanate of Oman. Tel.:+968-2450-3998 and/or +968-9571-9571-0982. E-male: marketing@thetop-expo.comWebsite:www.thetop-expo.com

January 18-20, 2018 SEHA Congress 2018 (Abu Dhabi,U.A.E.) The 12 edition of the SEHA international PaediatricConference is scheduled to be held at Rosewood Hotel in AbuDhabi, U.A.E For details contact: MENA Conference, PO Box:54210 Office No. 504 Abdulla Bin Darwish Bldg. Hamdan &Salam Street Junction, Abu Dhabi, U.A.E. Tel.:+971-2-4919888, Mobile: +971-56-503-3746. E-male: zandy@men-aconfence.com "website:www.menaconference.com/events/12sehaped/

January 23-25, 2018 ISWS 2018 (Dubai,U.A.E.)The first edi-tion of International Sport and Wellness Show (ISWS) isscheduled to be held at. Dubai World Trade Centre in Dubai,U.A.E For details contact: International Sports and wellnessShow, Marina Plaza, Level 29, Dubai Merina, P.O Box112229. Dubai, UAE. Tel.:+971-4-550-6395. E-mall :sales@isws.ae Website:www.isws.ae

January 29-01 February, 2018 Arab Health 2018 (Dubai,U.A.E) The largest gathering of healthcare and trade profes-sionals in the MENA region will be held at Dubai InternationalConvention & Exhibitions. Centre, Dubai, U.A.E. For detailscontact: Informa Life Sciences Exhibitions, Office No. 20:01Level 20, Sheikh Rashid Tower, Dubai U.A.E Tel.:+971-4-3365161. E-Mail: info@lifesciences-exhibitions.com web-site:www.arabhealthonline.com

January 30-31,2018 Patient Experience Asia Summit 2018(Singapore.) A Conference based on the theme of ElevateNewGen Patient-Centric Care: Leadership and lnnovation isscheduled to be held in Singapore.The conference is basedon lmproving care delivery, patient satisfaction, improvingreporting and compliance, improving efficiency and quality ofhospital services etc. For details contact: Fleming Events.Vajnorska 100/A, 83104,Bratislava, Slovakia.Tel.: +421-257-272-100. E-mail:info@fleming.events;Wepsite:https://fleming.events/events/pharma/patient-experience-asia-summit-singapore#

February 5-8, 2018 Medlab 2018 (Dubai, U.A.E)The world'slargest laboratory exhibition and congress "MEDLAB" isscheduled to be held at Dubai international Convention andExhibition Centre in Dubai, U.A.E. For details contact: InformaLife Sciences Exhibition,Office No 20:01, Level 20, SheikhRashid Tower, Dubai World Trade Centre, Dubai, U.A.E.Tel.:+971-4-336-7334. E-mail: medlabme@informa.com.Website:www.medlabme.com

February 7-12, 2018 PLASTINDIA (Ahmedabad, Gujarat,India.) 10th International Plastics Exhibition, conference andconvention will be held at Gandhinagar, Ahmedabad, Gujarat,India. The Event will focus plastics in Medical and Healthcare(Medical Devices, Pharmaceuticals, Diagnostics, MedicalPackagaing etc.) For details contact: Plastindia Foundation,401, Landmark 'B' Suren Road Off Andheri Kurla Road,Andheri (E) Mumbai-400093, India. Tel.:+91-22-26832911/14, Fax: +91-22-26845861. E-mail:Plastindia@vsnl.com;Web.:www.plastindia.org

February 9-11, 2018 ICHCA 2018 (Valencia, Spain.) An inter-national Congress on hypertension in Children and adoles-cents in scheduled to be held in Valencia, Spain. For detailscontact: Paragon Group, 18 Avenue Louis-Casai, 1209Geneva, Switzerland. Tel:+41-22-5330-948, Fax: +41-22-5802-953. E-mail; secretariat@htpaediatrics.comWebsite:www.htpaediatrice.com

February 15-17, 2018 India Medical Device 2018 (Bengaluru,India.) The 3rd edition of international exhibition and confer-ence on medical device sector is scheduled to be held atBangalore international Exhibition Centre in Bengaluru, India.For details contact: Federation Of Indian Chambers OfCommerce And Industry (FICCI), Karnataka State CouncilVITC Building, 1st Floor, Kasturba Road, Bangalore 560001,India. Mobile:+91-9945790735Email:bk.nayak@ficci.com;Website:www.indiamediex-po.in

February16-17, Annual Case Bosed Approach toControversies in Cardiovascular Diseases 2018 (Dubai,U.A.E.) The 8th edition of case based approach to controver-sies in cardiovascular diseases is scheduled to be held atMohammed Bin Rashid-Academin Medical Center in DubaiU.A.E. For details contact; infoPlus Events LLC, Suite 1406Lake Central Tower, Al Abraj Street, Burj Khalifa Community.P.O.Box 71108, Dubai, U.A.E.Tel.:+971-4-4218996,Fax:+971-4-4218838. E-mail: marketing@infoplusev-ents.com; Website:www.cvuae.com

February 22-23, 2018 EMEL 2018 (Dubai, U.A.E) The 4thedition of Emirates Endometriosis League (EMEL) confer-ence on Endometriosis and Uterine Disorders is scheduled to

be held at Marriott Hotel, Dubai, U.A.E. For details contact:InfoPlus Events LLC-Dubai, Suite 1406, Lake Central Tower,AI Abraj Street, Burj Khalifa Community P.O. Box 71108.Dubai, UAE. Tel.: +971-4-4218996, Fax:+971-4-4218838. E-mail Marketing@InfoPlusEvents.com;Website:www.endometriosisuae.com/4thEMEL

February 21-23, 2018 Medical Japan 2018 (Tokyo, Japan)The 4th edition of international expo and conference, MedicalJapan, dedicated to producs/services/technologies for health-care, clinical testing, diagnostics and medicine is scheduledto be held at INTEX Osaka in Japan. For detailscontacet:Reed Exhibitions Japan Ltd.. 18F Shinjuku-NomuraBldg.. 1-26-2 Nishishinjuku, Shinjuku, Tokyo 163-0570,Japan. Tel .:+81-3-3349-8509, Fax :+81-3-3349-4922. E-mail: medical:www.medical-jpn.jp

February 22-24, 2018 MEDITEC 2018 (Mohali, Chandigarh,India.) India's pioneer medical equipment and technologiesexhibition is scheduled to be held at NIPER, SAS Nagar,Mohali in Chandigarhm India. For Details contact: OrbitExhibitions Pvt. Ltd.. 103 Navyug Industrial Estate. TJ RoadSewri (W) Mumbai-400015, India. Tel.;+22-2410-2801/03. E-mail: harikrishnan@orbitexhibitions.com:Website:www.medite.co.in

February 23-25, 2018 MEDICALL 2018 (Hyderabad,India)The 19th editon of India's B2B Medical Equipment andHospital needs exhibition is scheduled to be held at HitexExhibition Centre on Hyderabad, India. For details contact:Medexpert Business Consultants Pvt Ltd, 199, 7th floor, LezChurh Road, Mylapore, Chennai, 600-004 Tamilnadu. E-mail:info@medicall.in :Website: http//www.medicall.in

February 26-28, 2018 IFM 2018 (Dubai, U.A.E.) The 5thInternational Family Medicine Conference & Exhibition (IFM)will be held at Dubai International Convention & ExhibitionCentre, Dubai, UAE. For details contact: INDEX Conferences& Exhibitions Org. Est., INDEX Holding Headquarters, P.O.Bax: 13636, Road # D-62, Opp. Nad AI Hamar, Dubai, UAE.Tel.: +971-45208888 Fax:+971-43384193. E-mail:index@emirates.net.ae: Website:www.index.ae

February 17-March 1, 2018 Duphat 2018 (Dubai, U.A.E)The 23rd edition of Dubai International Pharmaceuticals andTechnologies Conference and Exhibition is scheduled to beheld at Dubai International Convention and Exhibition Centrein Dubai, U.A.E. for details contact: INDEX Conferences &Exhibitions Organisation Est, Headquarters, Road# D-62Opposite Nad AI Hamar, Dubai, United Arab Emirates Tel.:+971-4-520-8888 Fax: +971-4-338-4193. E-mail:info@duphat.ea : Website:www.duphat.ae

March 2-4, 2018 Medicare Colombo 2018 (Clombo, Srilanka.) The 9th edition of Sri Lanka's only national healthcareexhibirion, 'Medicare 2018' is scheduled be held at theSirimavo Bandaranaike Memorial Exhibition Hall in Colombo,Sri Lanka. For details contact: Global Trade Fairs, No. 70-A,R.V.L. Nagar Uppilipalayam (post),Coimbatore 641015,Tamilnadu, India, Mobile:+91-960-020-0400, Tel .;+91-422-259-0407. E-mail:gtfcbe@gmail.com and/ormadhawa@aitkenspence.lk Website:www.medicare.lk

March 3-5, 2018 MedHealth Kenya 2018 (Nairobi, Kenya) AnInternational trade exhibition on Hospital supplies, Medical,Surical, Laboratory equipment, Pharmaceutical etc is sched-uled to be held at KICC in Nairobi, Kenya. For details con-tact:Gtow Exhibitions, P.O.Box 103574, Dubai, U.A.E.Tel.:+971-4-3964906, Fax:+971-4-3964904. E-mail:Maggie.z@growexh.com ;Website:http//www.growexh.com/medhealth

March 5-7, 2018 Africa Healthcare and Dental Summit 2018(Olympia, London, U.K.) The 5th edition of Africa HealthcareWeek is scheduled to be held at Olympia in London, UnitedKingdom, This business event shall provide high-leval discus-sion and meetings into the investment opportunities and tech-nology opportunities and technology procurement require-ments of Africa's healthcare industry. A concurrent Dentalsummit shall also be held along with Africa HealthcareSummit 2018 For details contact: Oliver Kinross, 1-3 WorshipStreet, London, EC2A 2AB, U.K Tel.:+44-203-058-2381. E-mail: Victoria.fields@oliverkinross.com ; Website:www.africahealthcareweek.com

March 7-10, 2018 Tunisia Health Expo 2018 (Tunis, Tunisia.)An event for public and private medical fraternity to know themost recent technologies and development in all the branch-es of the health sector is scheduled to be held at Exhibitionpark and the International Trade Centre in Tunis, Tunisia. Fordetails contact Society Doe Foires International De Tunis,parc DesExpositions Et Centre De Commerce InternationalB.P. N1 2015 Le Kram, Tunis, Tunis, Tunisia. Tel.; +216-71-973-111/976-111, Fax: +216-71-971-666. E-mail:itf.com@fkra.com.tn; Website:http://www.tunisia-healthexpo.com.tn

March 13-14, 2018 Future Healthcare (London UnitedKingdom.) An International exhibition and conference onfuture healthcare is scheduled to be held at London, Olympiain United Kingdom For details contact: Pri-Med Global Plc, 14Hanover Street, Hanover Square, London WIS IYH, U.K.

Tel.:+44-0203-470-4666. E-mail: info@futurehealth-careuk.com

March 13-15,2018 Intermed 2018 (Mosscow, Russia.) The9th edition of International Exhibition dedicated to medicaltreatment abroad, InterMed, is scheduled to be held atExpocentre Fairgrounds in Moscow, Russia For details con-tact: Prime Expo. 24A Yakubovicha st. Sr Petersburg,190000, Russia. Tel.:+7-812-380-6000. E-mail:med@prim-expo.ru: Website: www.intermedexpo.ru

March 15-19, 2018 KIMES 2018 (Seoul, Korea.) The 34thedition of Korea International Medical and Hospital EquipmentShow is scheduled to be held at COEX in Seoul, Korea. Fordetails contat: E & Ex Inc.(KIMES 2018 Secretariat),Rm.2001, WTC,511, Yeongdong-dearo, Gangnam-gu, Seoul,06164, Republic of Korea. Tel.:+82-2-551-0102, Fax:+82-2-551-0103, E-mail: kimes@kimes.kr; Website:www.kimea.kr

March 16-18, 2018 Meducal Fair India 2018 (Mumbai, India.)The 24th edition of International Conference and exhibition isscheduled to be held at Bombay Convention and ExhibitionCentre in Mumbai, India For details contact: MesseDusseldorf India Pvt.Ltd., 302-302 A. 3rd Floor, SalconAurum, Plot No 4. Jasola District Centre, Near Delhi-110025,India. Tel.:+91-11-4855-0057 and/or TyagiS@md-india.com; Website:www.medicalfair-india.com

March 22-25 2018 Expomed Eurasia 2018 (Istanbul, Turkey,)The 25th edition of the event dedicated to Medical Analysis,Diagnosis, Treatment. Rehabilitation Paduct, Device,System, Technology, Equipment and Hospitals Fair is sched-uled to be held at Tuyap Fair and Congress Centre in Turkey,Istanbul. For details contact: Reed Tuyap Fuarcilik A.S., E-5Roadway, Gurpinar Crossroad Reed Tuyap Fuarcilik A.S., E-5 Roadway, Gurpinar Crossroad 34500, Buyukcekmece,Istanbul, Turkey, Tel.:+90-212-867-1100, Fax:+90-212-886-6698. E-mail:info@reedtuyap.com.tr;

April 2-4, 2018 Medlab Asia 2018 (Suntec City, Singapore)An international event which shall bring together leading lab-oratory experts, scientists, researchers and clinicians toexchange and share their experiences and research clini-cians to exchange and share their experiences and researchresults on all aspects of laboratory medicine and clinicalresearch is scheduled to be held at suntec SingaporeConvention & Exhibition Centre in Singapore. For details con-tact: Informa Life Sciences Exhibitions Office No. 20:01. Level20, Sheikh Rashid Tower, Work Trade Centre. Dubai U.A.E.Tel.:+971-4-407-2574and/or+971-4-336-5161, Fax:+971-4-336-4021. E-mail :marlon: +971-4@informa.com ;Website: http://www.medlabasia.com

April 2-4, 2018 Rehacare & Orthopedic China 2018(Guangzhou, China.) The biggest event on Rehabilitation,Rehacare and Orthopedic dedicated to specially challengedPeople is scheduled to be held at poly World Trade Centre inGuangzhou, China. For details contact: R&OC committee,f/4,406, Tower B, Poly World Trade Centre, No. 1000 XinGang Dong Road, Haizhu District, Guangzhou, China.Tel.:+86-20-66224913, Fax:+86-20-66318832. E-mail:Maggie@cantonrehacare.com ; Website: http://en.can-tonrehacare.com

April 3-5, 2018 Kuwait Health 2018 (Mishref, Kuwait.) TheSecond edition of the largest healthcare event in Kuwait isscheduled to be help at Kuwait International Fair Grounds inMishref, Kuwait. For details contact: ATEX InternationalExhibitions L.L.C., P.O Box 413520 Business Bay, Dubai,Unted Arab Emirates, Tel.:+971-4-424-9988and/orMob.:+971-55-775-1524. E-mail: love@attexinternation-al.com and/orinfo@atexinternational.com. Website:http;//www.kuwaithealthexhibition.com

April 3-5, 2018 ISF Kuwait 2018 (Mishref, Kuwait,) Kuwait'sinternational trade exhibition dedicated to sports, Fitness andHealth is International Fair Ground in Mishref, Kuwait. Fordetails contact: ATEX International Exhibitions L.L.C., 301Opal Tower, Tesla Group. Business Bay, P.O. Box 413520,Dubai, United Arab Emirates. Tel.: +971-4-424-9988,Fax:+971-4-374-6014. E-mail: love@atexintrnational.com; Website: www.isf-me.com/kuwait

April 4-6-, 2018 Lab Indonesia 2018 (Jakarta, Indonesia.)The5th edition of Indonesia's Laboratory, Scientific AnalyticalEquipment and Services Exhibition and Conference is sched-uled to be held at Jakarta Convention Centre in Jakarta,Indonesia. For details Indonesia, JI. Maritim No . 4A3,Cilandak Barat Jakarta, 12430, Inonesia. Tel .:+62-21-7590-2647/6812, Fax:+62-21-7590-1572. E-mail: info.ptite@ite-asia.com ; Website:www.lab-indo.com

April 5-7,2018 ECCC 2018 (Dubai, U.A.E.) The 14th editionof Emirates Critical Care Conference (ECCC) is scheduled tobe held at event Centre in Dubai Festival City, U.A.E. Fordetails contact: Infoplus Events LLC, Suite 1406, Lake CentralTower, AI Abraj Street, Burj Khalifa Community, P.O. Box71108, Dubai, UAE. Tel.:+971-4-4218996, Fax:+971-4-42188638. E-mail: marketing@infoplusevents.comWebsite:www.accc-dubai.com

RRooppkk ddhh nnss[[kkHHkkkkyyRopk ds j[kj[kko esa lcls igyk vkSj egRoiw.kZ dk;Z Ropk dh liQkbZ dk gksrk gS- llT;knk xje ikuh ds ctk; xquxqus ikuh dk ç;ksx Ropk dks dksey j[kus esa enn djrkgS- ll gÝrs esa 2 ckj vius psgjs vkSj 'kjhj dh Ropk dks lkSE; LØc ls lkiQ dfj,]ftlls fd e`r vkSj >qjhZnkj fn[krh Ropk lkiQ gks tk,- ll ?kwi esa tkrs le; /wi dkp'ek t:j igusa- ll jkf=k esa lksus ls igys vius psgjs dks gYds ikuh ls lkiQ djsa-vk;qoZsn dk fl¼kar lexz n`f"Vdks.k dk gS] blfy, bl i¼fr ds vuqlkj gekjh Ropkij gekjs [kku iku dk lh/s rkSj ij vlj iM+rk gS- vr% Åijh ns[kHkky ds lkFk&lkFkgesa vanj ls Hkh viuh Ropk ds çdkj ds vuqlkj Ropk dks lgh çdkj ls çHkkfor djusokys rRoksa dk mi;ksx vius [kkus ihus esa djuk pkfg,- vk;qoZsn esa Ropk dh ns[kHkkyRopk ds çdkj ij fuHkZj djrk gS- vk;qoZsn ds f=knks"k fl¼kar ds vuqlkj Ropk rhu çdkjdh gksrh gS% okr Ropk] fiÙk Ropk] diQ Ropk] Ropk ds rhuksa çdkjksa dh ns[kHkky dsfy, fVIl fuEufyf[kr gSa%& ddiiQQ RRooppkk ddhh nnss[[kkHHkkkkyy %%&& bl çdkj dh Ropk esa ikuh vkSjfeêðh nksuksa dh fo'ks"krk;sa gksrh gSa- ;g rSyh;] eksVh] ihys jax dh] eqyk;e çdkj dhRopk gS- vkSj bl çdkj dh Ropk ij /wi dk vlj de gksrk gS- rSyh; vkSj eksVh gksusds dkj.k bl çdkj dh Ropk dks fu;fer rkSj ij fMVkWDlhfiQds'ku dh t:jr jgrh gS-ll vxj vkidh Ropk dk çdkj diQ g-S rks vkidks dM+ok dlSys vkSj rh[ks Lokn okys[kk| inFkkZs dk lsou djuk pkfg,A ll ehBs vkSj rys gq, [kk| inkFkkZs ls cps D;ksafd

;g Ropk dk rSyh;iu ckb;ka vklkuh ls iM+ tkrh gSa- fiÙk Ropkdks BaMd vkSj iks"k.k nksuksa dh t#jr gksrh gS- ll vxj vkidh Ropkdk çdkj fiÙk g-S rks vkidks ehBk] jlnkj iQyksa esa ik;k tkus okykehBk dM+ok vkSj dlSys Lokn okys [kk| inkFkZ vPNs yxrs gksaxs- llBaMs ehBs vkSj jlnkj [kk| inkFkZ dk T;knk lsou djsa- ll iQy vkSjlfCt;ksa esa f'keyk fepZ] czksdksyh] vadqfjr vukt] xksHkh] iQwyxksHkh]vtokbu] eDdk] ddM+h] lykn] e'k:e] eVj] pqdanj] vkyw] LDoS'k]rksjh] lsc] dsyk] [ktwj] ukfj;y] vaxwj] yhph] vke] rjcwt] vukjvkfn dk mi;ksx djsa- ll is; inkFkZ esa BaMs is;] nw/] ikuh] ukfj;ydk nw/] iQy vkSj lfCt;ksa ds jl dk T;knk lsou djsa- ookkrr RRooppkkddhh nnss[[kkHHkkkkyy%%&& bl çdkj dh Ropk iryh] uktqd] :[kh gksrh gS- okrRopk tYnh ls viuh ueh NksM+ nsrh gS vkSj Nwus ij BaMh çrhr gksrhgS- bl çdkj dh Ropk ij vxj è;ku u fn;k tk;s rks bl ij >qfjZ;katYn iM+rh gSa- okr Ropk iryh] uktqd] :[kh vkSj bl ij >qfjZ;katYn iM+rh gSa blfy, bl çdkj dh Ropk dh ns[kHkky ds fy, ftuinkFkkZs dk ç;ksx fd;k tk;s og Ropk dks Hkjiwj iks"k.k nsus esa l{kegksus pkfg,- :[ksiu vkSj >qfjZ;ksa ls cpus ds fy, rsy vkSj tM+h cwfV;ksadks feyk dj ç;ksx djuk pkfg,- rsy :[ksiu ds fy, vkSj tM+hcwfV;ka iks"k.k nsus ds fy, gksrh gS- vxj vkidh Ropk] okr Ropkçdkj dh gS rks vuq'kklu ls lgh le; ij lksus dk] lgh le; ijlgh [kkuk [kkus dk vkSj ,d fu;fer fnup;kZ dk ikyu djus lsRopk ij fu[kkj cuk jgrk gS- xquxqus rsy ls gj jkst ekfy'k djus ls

'kjhj esa jÙkQ lapkj vPNk gksrk gS- ll xeZ] Hkkjh] ue] ehBs [kk| inkFkZ dk T;knk lsoudjsa- ll iQy vkSj lfCt;ksa esa xktj] cSaxu] ykSdh] tSrwu] díw] ewyh] 'kdjdan]ikyd]rksjh] [kqckuh] dsyk] psjh] rktk vathj] vkM+w] [kêðs iQy] [ktwj] vke] iihrk] vaxwj] tkequ]vukukl] Iye dk mi;ksx djsa- ll is; inkFkZ esa xeZ is; inkFkZ] gcZy ;k elkysnkj pk;]xeZ nw/]ciQZ ds fcuk iQy vkSj lCth ds jl dk ç;ksx djsa-

GSK Receives US FDA Nod For labelupdate on ICS/LABA Combinations in

AsthmaGlaxoSmithKline has announced it has received approval by the USFood and Drug Administration (FDA) of labelling changes to removethe boxed warning from inhaled corticosteroid (ICS) / long-acting beta2agonist (LABA) combination medicines, including BREO ELLIPTA (flu-ticasone furoate/vilanterol, FF/VI), ADVAIR DISKUS (fluticasone propi-onate/salmeterol, FSC) and ADVAIR HFA. The FDA also approvedupdates to the Warnings and Precautions section of labelling for theICS/LABA class. These labelling updates were approved on December20, 2017, after a review of safety data from 4 randomized controlledsafety trials submitted by three companies, including GSK. This deci-sion follows a Post-Marketing Requirement, issued by the FDA in2010, for manufacturers of LABA-containing medicines at that timeindicated for the treatment of asthma, to each conduct a large-scalestudy on the safety of LABAs when used in combination with ICS inadults and adolescents with asthma. Each of the large-scale safety tri-als were randomised, double-blind, 26-week, active-controlled clinical trials comparing the sponsor-specificICS/LABA to the same dose of the ICS. As the manufac-turer of FSC, the only ICS/LABA approved in children 4-11 years of age in the US at that time, GSK also con-ducted a separate, similarly-designed study in this agegroup. GSK reported results from two safety studies thatcompared FSC, an ICS/LABA combination containingFluticasone Propionate (FP) and salmeterol, to FPalone. The studies showed that there was no excessrisk associated with salmeterol when used in combina-tion with FP, when used to treat both adolescent andadult patients with asthma (AUSTRI, SAS115359), andchildren aged 4 - 11 years (VESTRI, SAS115358), asassessed by the composite endpoint of asthma-relatedevents (death, intubations or hospitalisations).

Mylan, Natco Take Early LeadWith Enhanced Safety ProfileGeneric Drug For Hepatitis B

Two companies, one a global major, Mylan and theother, Hyderabad-headquartered niche pharma product-maker Natco Pharma, have taken an early lead inlaunching generic version of Tenofovir Alafenamide, TAF,25 mg, a once-daily tablet for the treatment of chronichepatitis B in adults. On December 7th, Mylan launched'HepBest', which it called, "the first drug approved ineight years for management of chronic Hepatitis B infec-tion in India." The launch was done by MylanPharmaceuticals in India. Just over 10 days later, on December 18th,Natco Pharma informed the bourses on Monday that it was launchingthe drug under its brand 'TAFNAT,' in India. The drug TAF, it says,demonstrates comparable efficacy, with an enhanced renal and bonesafety profile as compared to earlier formulation of tenofovir (tenofovirdisoproxil fumarate). TAFNAT is manufactured under license fromMedicines Patent Pool (MPP) and Gilead Sciences. Natco priced itsgeneric medicine of TAFNAT at an MRP of INR 1900/- for a monthlypack of 30 tablets for the India market. According to Dr Jyoti Joshi,head, South Asia at the Center for Disease Dynamics, Economics andPolicy, based in New Delhi, "generic drugs such as these open doorsfor access to medications for poor patients such as tribals in India andperhaps may alsoencourage the govern-ment to take it forwardin its public health pro-gramme for targetedtreatments." Mylan, offcourse in its mediarelease, referred to thedimension of the prob-lem. It says, accordingto World HealthOrganization (WHO)estimates, more than 2billion people worldwideare infected with thehepatitis B virus (HBV),of which more than 240million have chronicliver infection. Thesepatients are at risk of developing serious illness and death, largelyresulting from liver cirrhosis and liver cancer. The company also quotes,Rakesh Bamzai, its President, India and Emerging Markets, as saying,"India has an estimated 40 million HBV carriers, of which 15 per cent to25 per cent could go on to suffer from cirrhosis and liver cancer." In2014, Mylan signed an agreement with Gilead to enhance access toTAF-based HIV treatments in developing countries. As part of thelicensing agreement, on US Food and Drug Administration (FDA)approval, Mylan received a technology transfer from Gilead, enabling itto manufacture low-cost versions of TAF.

Red Meat May Put You at Cancer RiskCancer Research UK has acknowledged a correlation between processedand red meats and the deadly disease. According to experts, the only way tobe certain that it hasn't been affected by tumours is by taking a look at theentire animal before it's cut up because consuming diseased product mayincrease your risk of developing cancer, reports eaily star online. Author TimKey from the University of Oxford said, "Cancer Research UK supports IARC'sdecision that there's strong enough evidence to classify processed meat as acause of cancer and red meat as a probable cause of cancer." "We've knownfor some time about the probable link between red and processed meat andbowel cancer, which is backed by substantial evidence. They warned thateven if you are buying it from a supermarket, then also there is no certaintythat cancer has been chopped out by butchers. Cancer Research UK and theInternational Agency for Research on Cancer classify processed meats,including bacon and sausages, as "causes of cancer". The team advises pub-lic to reduce their meat intake if it's excessive. "This decision doesn't mean youneed to stop eating any red and processed meat. But if you eat lots of it youmay want to think about cutting down," the researchers concluded.

vvkk;;qqoossZZnn vvkkSSjj ee//qqeessggizkIr tkudkjh ds vuqlkj vk;qosZn ds vuqlkje/qesg dk eq[; y{k.k ikpu ra=k esa vlekU;ifjorZu gksuk ,oa bUlqfyu ds L=kko esa deh gksukbR;kfn gS- vk;qosZn ;g dgrk gS fd e/qesg dkmipkj fliQZ nok vkSj i;kZIr vkgkj ds lsou lsfd;k tk ldrk gS- vk;qosZn ;g Hkh dgrk gS fd;fn e/qesg dk mipkj le; ls ugha fd;k tk, rks;g vka[k dh leL;kvksa] tksM+ksa esa nnZ] uiaqldrk]xqnsZ dh foiQyrk vkSj Hkh fofHkUu izdkj dh dbZtfVyrkvksa dks tUe ns ldrk gS- D;ksafd e/qesg dks,d egkjksx ds :i esa oxhZd`r fd;k tkrk gS-

??kkuuss cckkyykkssaa llss nnnnZZ eessaa vvkkjjkkeerrdd&&ddiiwwjj ddss ggSSaa ;;ss ttccjjnnLLrr iiQQkk;;nnssizkIr tkudkjh ds vuqlkj diwj ds reke iQk;nsgSa- vkSj ;g ,d mi;ksxh vkS"kf/ gS- diwj dksdbZ nokb;ks a esa Hkh bLrseky fd;k tkrk gS-gkykafd blds dbZ C;wVh csusfiQV~l Hkh gSa- Ropklaca/h ijs'kkfu;ks a esa diwj dk [kklk iz;ksx fd;ktkrk gS- baiQSD'ku ;k tyus ij diwj dk ysicgqr vkjke nsrk gS- ;gka tkusa diwj ds ;s rekeiQk;ns&ukfj;y ds rsy vkSj diwj dks feykdjeaqgklks a] tys ;k pksV ds nkx ij yxk,a- dqNfnuks a esa buds fu'kku feV tk,axs- Ropk vxj tytk, rks bl ij diwj ;k diwj dk rsy yxk,a-blls tyu [kRe gksxh vkSj baiQsD'ku dk [krjkVysxk- [kqtyh dh leL;k gks ;k Ropk esa iQaxybaiQSD'ku gks xbZ gks rks izkWCye okyh txg ijukfj;y ds rsy esa diwj Mkydj yxk,a- vkjkefeysxk- pksV yxus] dVus ;k ?kko gks tkus ijdiwj feyk ikuh yxkus ls tYn vkjke feysxk-ukfj;y rsy esa diwj feyk,a bls xquxquk dj fljdh ekfy'k djsa vkSj ,d ?kaVs ckn flj /ks ysa-

MaSMªiQ dh izkWCye [kRe gksxh vkSj cky ?kus oetcwr cusaxs- vkWfyo vkW;y esa diwj feykdjflj dh ekfy'k djsa- LVªsl vkSj fljnnZ dhizkWCye nwj gksxh- ?kj esa diwj dk /qvka djus lsvklikl ekStwn cSDVhfj;k [kRe gksrs gSa- bllsbaiQSD'ku dk [krjk Vyrk gS- nkar nnZ gksus ijnnZ okyh txg ij diwj dk ikmMj yxk,a- tYnjkgr feysxh- lnhZ twdke gksus ij fry ;kukfj;y rsy esa diwj feykdj Nkrh] ekFks ;k fljij yxkus ls jkgr feyrh gS- blds ikuh ls Hkkiysus ij Hkh vkjke feyrk gS- jkr dks lksus ls

igys dPps nw/esa tjk lk diwjikmMj Mkysa vkSj:bZ dh enn lsbls psgjs ij yxkysa- 15 feuV cknpsgjk /ks ysa- ,slkdjus ls RopkLoLFk o nednkjcusxh- ,dfxykl ikuh esa,d pEepvtokbu Mkydjmckysa- ikuh jgtk,] rks blesatjk&lk diwjMkydj ih tk,a-,slk djus ls isV

nnZ esa vkjke feyrk gS- iQVh ,fM+;ks a dh leL;knwj djus ds fy, xquxqus ikuh esa FkksM+k&lk diwjvkSj ued Mkysa- bl ikuh esa dqN nsj iSj MkydjcSBsa vkSj fiQj LØc djus ds ckn xquxquk ukfj;yrsy yxk ysa- diwj dks nslh ?kh esa feykdj eq¡gds Nkyksa ij yxk,a- jkgr feysxh-

ççkkssVVhhuu ddss ddkk;;ZZl 'kjhj ds Årdksa dh ejEer vkSj mudh j{kk djuk- l çlj.kh; nkc dk;e j•uk-l L=kh dks æqX/loku dky esa nqX/ fuekZ.k ds fy, çksVhu dh vko';drk gksrh gS- lçksVhu 'kfÙkQ çnku djrh gSA- l xHkZoLFkk esa Hkwf.k;k fodkl- l çksVhu ds isf'k;ksa] 'kjhjds vaxks] var% L=kkoh vFkok ufydkghu xzafFk;ksa vfLFk vk/k=kh] nk¡rks] Ropk] ckyks rFkkuk•quks vkfn dh o`f¼ ,o fodkl ds fy, vko';d gksus ds dkj.k buls f'k'kqvks vkSjcgqr NksVs cPps esa 'kjhj dk fuekZ.k gksrk gS- l çksVhu dk 'kjhj dh jksx{ke ;kaf=kdh lslaca/ gksrk gS- ddqqNN iinnkkFFkkkkZZss ddkk llaa''kkyyss""kk..kk ttSSllss%%&& gkekZsu tSls bUlqfyu rFkk FkkbjkWfDlu litkTek çksVhu l vUVhckWfM;k l gheksXyksfcu l ,Utkbe tSls fVªfIlu ,o isfIlu lLdUnd dkjd ççkkssVVhhuu ddss LL==kkkkssrr%%&& ççkkssVVhhuu ddss ttUUrrqq LL==kkkkssrr %%&& tUrq mnxe dh çksVhu nw/]iuhj] vaMks] ek¡l ,o eNyh esa ikbZ tkrh gS- l tUrq çksVhuksa esa lHkh vko';d ,feuksvEy mi;qDÙk ek=kk esa gksrs gS vr% bUgs çFke Js.kh dk çksVhu Hkh dgk tkrk gS- ççkkssVVhhuuddss oouuLLiiffrr LL==kkkkssrr%%&& ouLifr çksVhu vukvks esa] nkyksa] frygu] dk"BiQyksa] iQyks rFkklfCt;ksa esa ikbZ tkrh gS- l ouLifr çksVhuksa esa ,d ;k nks vfeuks vEyksa dh deh gksrhgS vr% ouLifr çksVhuksa dks f}rh; Js.kh dk çksVhu dgk tkrk gS-

www.pharmafranchisee.new

''kkkkss// eessaa ccMM++kk ••qqyykkllkk]] bbll rrjjgg vvkkookktt iiggppkkuurrkkggSS eekkuuoo eeffLLrr""dd

ekuo dk fnekx 'kjhj dk lcls egRoiw.kZ vkSj uktqd fgLlk gksrk gS- gekjk iwjk 'kjhjefLr"d ls gh pyrk gS- vc rd gekjk foKku bl ckr ls vNwrk Fkk fd vkf•j gekjkfnekx vkokt dks fdl rjg igpkurk gS- ,sls esa gky gh esa fo¼kuksa ds gkFk ,d cM+hmiyfC/ yxh gS- oSKkfudksa us ekuo fnekx ds ,d vR;ar NksVs fgLls dh igpku dhgS] tks u fliQZ vkokt igpkuus esa] cfYd vkoktksa esa varj djus esa Hkh enn djrk gS-;g fjlpZ teZuh ds eSDl IySad baLVhVÔwV ds 'kks/drkZvksa us dh gS- fjlpZ esa •qyklkfd;k x;k gS fd gekjs fnekx esa iksLVhfj;j lqfifj;j VsEiksjy xkbfjl (,lVhth) vkoktdh igpku ds fy, ftEesnkj gS- ;g nkfgus iksLVhfj;j VsEiksjy yksc dk ,d Hkkx gksrkgS] tks Lru/kjh ds fnekx ds pkj çeq• Hkkxksa esa ls ,d gS- 'kks/drkZvksa us ;g Hkhdgk gS fd ftu yksxksa esa •kl rkSj ls nkfgus iksLVhfj;j VsEiksjy yksc esa pksV yx tkrhgS] mUgsa vkokt igpkuus esa eqf'dy gksrh gS- eSDl IySd baLVhVÔwV dh oSKkfudDykmfM;k jkslokMksfoV~t us dgk] pksV okys ejhtksa dh tk¡p ls irk pyk gS fd fnekxdk dkSu&lk Hkkx fdl dk;Z ds fy, ftEesnkj gS- ;fn fnekx dk ,d fuf'pr HkkxpksfVy gS vkSj bl otg ls ,d r; dk;Z ugha dj ikrk gS rks nksuksa vo;oksa dks ,dlkFk tksM+ ldrs gSa- bl 'kks/ dk çdk'ku if=kdk ^czsu* esa fd;k x;k gS- fliQZ brukgh ugha bl ekSds ij fo¼kuksa us efLr"d esa ?kko okys ejhtksa ;kfu fd LVªksd ls ihfMrksadk ijh{k.k fd;k vkSj mudh vkokt igpkus o lh•us dh {kerk dh Hkh tk¡p dh gS-

HHkkOO;; ''kkqqHHkkkkjjEEHHkkfldUnzkckn (gSnjkckn) loknankrk JJSS;;vvxxzzookkyy eekkssññ 0099884499116611001100 us eSMhdyniZ.k ehfM;k gkmQl dks M/S PatwariPharma ds HkO; 'kqHkkjEHk dh tkudkjhnh tks fd fnlEcj ekg 2017 ea s vk;ksftrgqvk- lekjksg es a ftykgSnjkckn @ fldUnzkcknds yxHkx lHkh Fkk sdo fjVsy nokO;olkf;;k a s u smifLFkfr ntZ djk;h-

loknankrk us voxr djk;k dh lEiw.k Z gSnjkckn ftys es a 'kk;ngh bruk HkO; cgqeaftyk Vª sfMax lS.Vj blls igys cuk gks- bldslapkyd JJhh tt;;iizzddkk''kk vvxxzzookkyy eekkssññ 0099884499999999886611 o budslqiq=k JJhh uuoouuhhrr vvxxzzookkyy eekkssññ 0099990088220000006688 ,oe~ llqqffeerrvvxxzzookkyy eekkssññ 0099998899992200446611 th us eSMhdy niZ.k ehfM;k gkmQlls vkeaf=kr iatkc izfrfuf/ jkgqy nso 'kekZ o xqtjkr izfrfuf/vkns'k R;kxh th dks Hkh fo'ks"k lEeku ls lq'kk sfHkr fd;k-

HHkkkkjjrr eessaa rriissffnndd ;;kk VVhhcchh ddss eejjhhttkkssaaddhh llaa[[;;kk DD;;kkssaa ddee uugghhaa ggkkss jjgghh ggSS\\{k;jksx (Vhch) ds 27-9 yko ekeyksa] bl jksx ls 42-3 yko

yksxksa dh ekSr vkSj çfr 1]00]000 yksxksa esa 211 u, laØe.kksa

ds dkj.k Hkkjr bl le; nqfu;k esa Vhch jksfx;ksa dh lcls

cM+h la[;k okyk ns'k gSA ,d rktk fjiksVZ esa ;g ckr lkeus

vkbZ gS- Hkkjr esa ,eMhvkj&Vhch jksfx;ksa dh la[;k lcls

T;knk gS vkSj fcuk igpku okys Vhch jksfx;ksa dh la[;k Hkh

de ugha gS- ,sls dbZ yko ekeys gSa] ftudh igpku gh ugha

gqbZ gS] u gh bykt 'kq: gqvk vkSj ;s yksx vHkh rd LokLF;

foHkkx ds jkMkj ij gh ugha gSaA Vhch ,d csgn laØked

chekjh gS- bldk bykt iwjh vof/ ds fy, r; nok,¡ lgh

le; ij ysus ls bls Bhd fd;k tk ldrk gS- Mªx jstheSu

;k nok ds bl iwjs dkslZ dks MkWV~l dgk tkrk gS vkSj bls

la'kksf/r jk"Vªh; Vhch fu;a=k.k dk;ZØe (vkj,uVhlhih) ds

rgr eqÝr çnku fd;k tkrk gS- ;g bl fl¼kar ij vk/kfjr

gS fd mPp xq.koÙkk okyh ,aVh&Vhch nok dh ,d fu;fer

vkSj fuckZ/ vkiwfrZ ls chekjh dk bykt gks ldrk gS vkSj

,eMhvkj&Vhch dh ?kVuk,a jksdus ds fy, Hkh bldk ç;ksx

fd;k tkuk pkfg,A bafM;u esfMdy ,lksfl,'ku (vkbZ,e,)

ds vè;{k iÁJh MkW- ds- ds- vxzoky us dgk] Vhch Hkkjr

esa tu&LokLF; dh ,d çeqo fpark gS- ;g u dsoy chekjh

vkSj e`R;qnj dk ,d çeqo dkj.k gS] cfYd ns'k ij Hkh ,d

cM+k vkfFkZd cks> Hkh gSA blds mUewyu ds fy, t:jh gS

fd 1]00]000 yksxksa esa ,d ls vf/d O;fÙkQ dks bldk u;k

laØe.k u gksus ik,- ;g rHkh laHko gS tc jksfx;ksa dks fcuk

#dkoV nok feyrh jgs vkSj mudh chekjh dk le; ij irk

yxk fy;k tk,-¸ mUgksaus dgk fd bykt esa dksbZ Hkh #dkoV

rsth ls ,eMhvkj&Vhch jksxh ds tksfoe

dks cko gSa] tks Vhch laØe.k dks iQSyus

ls jksdus esa enn dj ldrs gSa- l

Nhadrs] [kk¡lrs le; vius eq¡g ;k ukd

ds ikl gkFk j[k ysa- l tc vki

[kk¡lrs] Nhadrs ;k galrs gSa rc diM+s ;k

fV';w isij ls viuk eq¡g

Dr. Reddy's Laboratories announces thelaunch of Melphalan Hydrochloride for

Injection in the U.S. MarketHyderabad:- Dr. Reddy's Laboratories Ltd.Mob:- announced that it has launched MelphalanHydrochloride for Injection, a therapeutic equiva-lent generic version of Alkeran® (melphalanhydrochloride) for Injection in the United States

market approved by the U.S. Food and Drug Administration (USFDA).The Alkeran® brand and generic had U.S. sales of approximately $107million MAT for the most recent twelve months ending in October 2017according to IMS Health*. Dr. Reddy's Melphalan Hydrochloride forInjection is available in a carton containing one singledose clear glassvial of freeze-dried melphalan hydrochloride equivalent to 50 mg mel-phalan and one 10 mL clear glass vial of sterile diluent.

FDA Approves US label UPdate onICS/LABA Combinations in Asthma, Based

on Review of Safety DataGlaxoSmithKline Today Announced it has Received Approval by the US Foodand Drug Administration (FDA) of labelling changes to remove the boxed warn-ing from inhaled corticosteroid (ICS) / long-acting beta2 agonist (LABA) combi-nation medicines, including BREO ELLIPTA (fluticasone furoate/vilanterol,FF/VI), ADVAIR DISKUS (fluticasone propionate/salmeterol, FSC) and ADVAIRHFA. The FDA also approved updates to the Warnings and Precautions sectionof labelling for the ICS/LABA class. These labelling updates were approved onDecember 20th2017, after a review of safety data from 4 randomized controlledsafety trials submitted by three companies, including GSK. This decision followsa Post-Marketing Requirement, issued by the FDA in 2010, for manufacturers ofLABA-containing medicines at that time indicated for the treatment of asthma, toeach conduct a large-scale study on the safety of LABAs when used in combi-nation with ICS in adults and adolescents with asthma. Each of the large-scalesafety trials were randomised, double-blind, 26-week, active-controlled clinicaltrials comparing the sponsor-specific ICS/LABA to the same dose of the ICS. Asthe manufacturer of FSC, the only ICS/LABA approved in children 4-11 years ofage in the US at that time, GSK also conducted a separate, similarly-designedstudy in this age group. GSK reported results from two safety studies that com-pared FSC, an ICS/LABA combination containing Fluticasone Propionate (FP)and salmeterol, to FP alone. The studies showed that there was no excess riskassociated with salmeterol when used in combination with FP, when used totreat both adolescent and adult patients with asthma (AUSTRI, SAS115359),and children aged 4 - 11 years (VESTRI, SAS115358), as assessed by the com-

posite endpoint of asthma-related events (death, intubations or hospitalisa-tions).[1],[2] Both studies were completed ahead of the predefined FDA date ofJune 2017.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i

Medsol Pvt.Ltd.D-Gain (Cholecalciferol 60,000 IUSachet/Softules) ll CALCITE-CM (CalciumCitrate 1350mg + Vitamin D3 400 I.U. +Magnesium 50mg) ll Ibanplus (Ibandronicacid 150mg Tablets) ll Osteo Plus (Calcitriol0.25mcg + Calcium Carbonate 1250mg + Vit.K2-7 45mcg + Methylcobalamin 1500mcgZinc 7.5mg + Magnesium 50mg + L-MethylFolate 800mcg) ll Calcite-D (CalciumCarbonate 1250mg + Vitamin D3 500 I.U.) llIbanplus-Kit (Combikit of Ibandronic Acid150mg Calcium Citrate Malate 1250 +Calcitriol 25mcg) ll Osteoplus-M (CalciumCitrate Malate 500mg + Calcitriol 0.25mcg +Zinc 20mg + Magnesium 40mg) ll Alensol-D(Sodium Alendronate 70mg + Cholecalciferol5600 IU) ll Y-CLAST (Zoledronic acid 5mgSolution for infusion) ll Coll-CD Tablets(Collagen Peptide Type ll 40mg + RosehipExtract 275mg + Vitamin C 35mg Boswelliaserrata Extract (65%) 100mg) ll P-1K(Paracetamol (IR) 300mg + Paracetamol(SR) 700mg) Neurotin-NT (Pregabalin 75mg+ Nortriptyline 10mg Tablets) ll Coll-CDCapsule (Collagen Peptide Type ll 40mg +Rosehip Extract 275mg Vitamin C 35mg +Boswellia serrata Extract (65%) 100mg) llRAC SR (Rabeprazole 20mg + Aceclofenac200mg SR Capsules) ll Neurotin-P(Mthylcobalamin 750mcg + Pregabalin 75mgCapsules) ll Coll-CD Sachet (Collagen pep-tide 10gm + Glucosamine 1500mg + VitaminC 35mg Hyaluronic Acid 20mg + Vitamin D31000 IU Sachet) ll TremSol (Tramadol37.5mg + Paracetamol 325mg Tablets) llReXol gel (Diclofenac + Linseed Oil + MethylSalicylate + Menthol) ll LIDSOL (Linezolid600mg + Cefuroxime Axetil 500mg Tablets) llEIOS (Methylcobalamin 1500mcg + Vit. D31000 IU Folic Acid 5mg + Inositol 100mg +Vitamins + Minerals Tablets) ll Arrant (AlphaLipoic Acid 50mg + Omega-3 Fatty Acids500mg + Mecobalamin 1500mcg +Chromium 200mcg + Selenium 75mcgCapsules) ll Eios Fem (Ferrous AspartoGlycinate Eq to Elemental Iron 100mg L-Methylfolate 1mg + Mecobalamin 1500mcg +Pyridoxal-5-Phospahte 0.5mg Cholecalciferol2000 IU) ll Paro-DSR (Pantoprazole 40mg +Domperidone 30mg SR Capsules) Ph:-0120-4511800.

MacleodsCovatil 500/250/125 DT (Cefuroxime AxetilTablets) ll Covatil CV (Cefuroxime Axetil +Clavulanic Acid Tablets) ll Covatil LZ(Cefuroxime Axetil 500 mg + Linezolid 600mgTablets) ll Eazoheal (Trypsin 48mg +Bromelain 90mg + Rutoside 100mg Tablets)ll Enzoheal-D (Trypsin 48mg + Bromelain90mg + Rutoside 100mg + Diclofenac 50mg)ll Enzoheal ointment (Mupirocin +Bromelain) ll Acuclav 1g/625mg/375mg(Amoxicillin & Clavulanate Potassium) llLizomac (Linezolid 600mg Tablets) llLizomac-CX (Linezolid 600mg + Cefixime200mg Tablets) ll Macprot Activ (NutritionalPowder) ll Genpraz DSR (Rabeprazole20mg + IR Domperidone 10mg + SRDomperidone 20mg Tablets in Caps) llGenpraz LS ll Orpenem (Faropenem 200mgTablets) ll Nanomac silver Gel (NanoCrystalline silver gel) ll HEMOLIT Tube llBionect Tube ll Meromac (Meropenem2g/1g/500/250/200/125mg Inj.) ll MeromacPlus (Meropenem 1g + Sulbactam 500mg) llMeromac 2G ll Lizomac (Linezolid 600 mgI.V) ll Zicoplanin (Teicoplanin Inj.200mg/400mg) ll Tazomac (Piperacillin +Tazobactam 4.5g/2.25g/1.125g) ll ZONA-MAX (Cefoperazone + Sulbactam 200mg /1g / 1.5g / 3g Inj.) ll Acuclav I.V.1.2g/300mg/150mg (Amoxicillin &Clavulanate Postassium) Covatil I.V.1.5/750/250 (Cefuroxime Sodium Inj.) llFINAMAC (Paracetamol Infusion 1gm /100ml) ll Zilamac (Imipenem Cilastatin500mg Inj.) ll Accuzon (Ceftriaxone2g/1g/500mg/250mg/125mg IM/IV) llAccuzon Plus (Ceftriaxone + Sulbactam1.5g/750mg/375mg IM/IV) ll Accutaz-AS(Ceftriaxone 1gm + Tazobactam 125mg Injfor IM/IV) ll Kefpime (Cefepime HCL1g/500mg IM/IV) ll Colinem (ColistimethateSodium 2/1 Million I.U.) ll Amikamac(Amikacin Sulphate 500mg/250mg/100mgIM/IV) ll Netilmac (Netilmicin Sulfate Inj.10/25/50/150/300mg IM/IV) ll Zadimac(Ceftazidime + Tazobactam1.125g/562.5/281.25mg Inj.) ll Nupenta I.V.(Pantoprazole 40 mg) Mob:- 09359989528,09897624714.

ABBOTT HEALTH CAREPVT. LTD.

Amicolon Cap. ll Stemetil MD(Prochlorperazine maleate 5mg MouthDissolving tablets) ll ESOGA-RD(Rabeprazole 20 mg + Domperidone 30 mgSR) ll Essentiale L (EssentialPhospholipids, Nattermann Capsule) ll B-stil(Betahistine Dihydrochloride 8/16/24 mgTablets) ll PHENSEDYL (CodeinePhosphate IP 10 mg and ChlorpheniramineMaleate IP 4 mg per 5 ml) ll Supradyn(Vitamins + Minerals + Trace Elements) llPHENERGAN Tablets/Syrup/Injection(Promethazine HCI 10mg, 25mg Tabs, syrupIP 5 mg/ 5ml, Inj. 25 mg/ml) ll FLAGYL(Metronidazole 200mg, 400mg Tab., Susp.200mg/5ml) ll Cremaffin ll Cremaffin PLUSll Cremadiet (Processed epidermis ofispaghula) ll Cremadiet DUO (LactitolMonohydrate US-NF 10G+ispaghula husk3.5G) ll Cremalax (Sodium picosulphate10mg Tablets) ll Cremalax Liquid ll Eldicet(Pinaverium Bromide 50 mg Tablets) llEntamizole O ll Ganaton (ItoprideHydrochloride 50mg Tablets) ll GanatonTotal ll Ganaton OD (Enteric coated ItoprideHydrochloride SR 150mg Capsules) llLibrax (Chlordiazepoxide 5 mg + ClidiniumBromide 2.5 mg) ll Gut-Renew (ProbioticCapsules) ll Actnew (Acotiamide Tablets100mg) ll Pankreoflat (Pancreatin 170 mg +Activated Dimethicone 80 mg Tablets) llPankreoflat Liquid (Digestive EnzymeLiquid) ll THYROWEL (L-Tyrosine,Multivitamin & Minerals Softgel Capsules) llThyrocal D3 (Calcium Citrate Malate andVitamin D3 Tablets) ll Thyronorm (ThyroxineSodium Tablets) Thyrocab (CarbimazoleTablets I.P 5/10/20mg) Ph:- 022-67978888.

Alembic Corazon Pvt. Ltd.Rosave-Gold (Rosuvastatin 10/20mg +Clopidogrel 75mg + Aspirin 75mg) ll RosaveCV (Rosuvastatin 10/20mg + Clopidogrel75mg) ll Rosave (Micronized Rosuvastatin5mg / 10mg / 20mg / 40mg) ll Rosave F(Rosuvastatin 5mg / 10mg / 20mg +Micronized Fenofibrate 160mg) ll Rosave D(Rosuvastatin 5mg / 10mg / 20mg +Cholecalciferol 1000 IU) ll TriVogo (Voglibose0.2mg + Metformin 500mg + Glimepiride1/2mg) ll Vogo-M (Voglibose 0.2mg / 0.3 mg+ Metformin 500mg) ll Vogo (Voglibose 0.2mg/ 0.3mg) ll Alnex-NT (Pregabalin 75mg SR +Nortriptyline 10mg) ll Ibaxit-XR (FebuxostatXR 40mg / 80mg) Ph:- 0265-2280550, 0265-2280880, 0265-3007000.

Torrent PharmaAzulix ½ MF Forte (Glimepiride 1mg / 2mg +Metformin SR 1000mg Tablets) ll Azulix ¾MF (Glimepiride 3mg / 4mg + Metformin SR500mg Tablets) ll Azulix ¾ MF Forte(Glimepiride 3mg / 4mg + Metformin SR1000mg Tablets) ll Azulix 1/2, ¾(Glimepiride 1/2/3/4 mg Tablets) ll Tri-Azulix½ (Glimepiride 1mg/2mg + Pioglitazone7.5mg + Metformin SR 500mg Tablets) ll Tri-Azulix Forte ½ (Glimepiride 1mg/mg +Pioglitazone 7.5mg + Metformin SR 1000mgTablets) Ph:-79-22551912 / 66551912.

Zydus CadilaNucoxia D3 (Etoricoxib 90mg andCholecalciferol 600 IU) ll Cadigut llNucoxia Relax ll Ocid L ll Ocid DSR llCleerpeg ll Nucoxia P (Etoricoxib 60 mg &Paracetamol 325 mg Tablets) ll ATEN AM(Atenolol 50mg + Amlodipine 5 mg Tablets) llOxalgin DP (Diclofenac Potassium 50mg +Paracetamol 325mg Tablets) ll FALCIGO120 Inj (Artesunate 120 mg Injections) llOcid 20 (Omeprazole 20 mg Capsules) llOcid QRS (Omeprazole Magnesium 20mgTablets) ll ATEN 25/50 (Atenolol 25, 50mgTablets) ll LINID (Linezolid 600mg tablets) llOxalgin nano Gel (Diclofenac Sodium 1%w/w Nanoemulsion) ll LEVODAY(Levofloxacin Tablets) ll ARTE PLUS CD(Artemether 80mg + Lumefantrine 480 mgTablets) Ph:- 079-26868100.

Cipla Pvt. Ltd.Esomac ll Esomac-D ll Esomac-L llEsomac-IV (Esomeprazole Sodium for injec-tion 40 mg) ll Pylokit (Lansoprazole 30 mg +Tinidazole 500 mg + Clarithromycin 250 mg)ll Tenvir Hep-B ll MESALO OD(Mesalamine Delayed Release Tablets1200mg) ll MESALO Foam (Mesalazinefoam 1 g/actuation) ll Ento Foam(Hydrocortisone acetate foam 10% w/w) ll

RIXMIN (Rifaximin 400/ 550 mg) ll HeptulacFiber (Lactulose Solution USP) ll PANSTAL(Pancreatin 150 mg) Mob:- 09690446545.

Systopic Laboratories Pvt.Ltd.

Cyra-LS (Rabeprazole Sodium 20mg &Levosulpiride 75mg (SR) Enteric CoatedBilayered Tablets) ll Topp-LS (PantoprazoleSodium 40mg + Levosulpiride 75mg (SR)Enteric Coated Bilayered Tablets) ll ORVAS5/10, 20/40 (Atorvastatin 5mg / 10mg / 20mgTablets) ll ORVAS-FT (Atorvastatin 10mg +Fenofibrate (Micronised) 160mg Tablets) llROSYS 5/10/20 (Rosuvastatin 5mg / 10mg /20mg Tablets) ll ROSYS-FT 10(Rosuvastatin (Micronized) 10mg +Fenofibrate (Nano Particle) 145mg Tablets)

Ph:- 011-48150000.

Zuventus Healthcare Ltd.Rabifast 40/20 (Rabeprazole 40/20 mgTablets) ll Rabifast-DSR (Rabeprazole20mg pellets + Domperidone 30mg SR pel-lets Capsules) ll Rabifast-XL (Rabeprazole20mg pellets + Levosulpiride 75mg SR pel-lets Capsules) ll Rabifast-IV (LyophilisedRabeprazole 20mg) Ph:- 011 2704 4415.

Alembic Specia Ltd.CETANIL 5/10/20 (Clinidipine 5mg / 10mg /20mg Tablets) ll CETANIL-T 20 (Cilnidipine20mg + Telmisartan 40mg Tablets) llCETANIL-M (Cilnidipine 10mg + MetoprololER 50mg Tablets) ll CETANIL-T (Cilnidipine10mg + Telmisrtan 40mg Tablets) llCETANIL-T 80 (Cilnidipine 10mg +Telmisartan 80mg Tablets) ll CETANIL-TRIO(Cilnidipine 10mg / Telmisartan 40mg /Chlorthalidone 6.25mg & 12.5mg Tablets) Ph:-0265-2280550, 265-2280880, 265-3053333.

Pfizer LtdDolonex (IM 40mg/2ml, DT 20 mg /Gel 5mg)ll Dolonex Rapid 20mg (Piroxicam betacyclodextrin tablets 20 mg) ll Dalacin C(Clindamycin hydrochloride 150 mg & 300mg caps, Clindamycin phosphate 300 &600mg ampoules) ll Depo-Medrol 1ml/2ml(Sterile Methylprednisolone acetate suspen-sion USP 40 mg/ml) ll Becotrol Capsules(Methylcobalamin) ll Aboce5 (RabeprazoleSodium 20 mg (in beta-cyclodextrin) llAbove5-D (Rabeprazole 20mg +Domperidone 30 mg capsules) ll WysoloneDT (Prednisolone DT 20 mg / 10mg / 5mg)Ph:- 022 - 66932000.

MankindFLOKIND-D (In Chronic Fatigue & MuscleCramps Tablets) ll Nurokind-LC(Mecobalamin 1500 mcg + Folic Acid 1.5 mg+ L-Carnitine 500 mg Tablets) llDYNAGLIPT-M (Teneligliptin 20 mg +Metformin 500 mg Sustained ReleaseTablets) ll DYNAGLIPT-M Forte (Teneligliptin20 mg + Metformin 1000 mg SustainedRelease) ll DYNAGLIPT (Teneligliptin 20 mgTablets) Ph.:- 011-46541111.

LUPIN LIMITEDAcogut (Acotiamide Hydrochloride Hydrate100 mg) ll Pegalup (Polyethylene Glycol,Sodium Chloride, Sodium Bicarbonate &Potassium Chloride Concentrate for oralsolution) ll Rcifax 550/400/200 (Rifaximin550,400, 200 mg Tablets) ll Ulyses (TheLiver Saviour) Ph:- 0120 4048200.

Alembic Pvt. Ltd.WIKORYL (Tablets / Suspension / Drops) llZEET (Diphenhydramine HCI-100mg +Ammonium Chloride-100mg + SodiumCitrate-60mg /5ml Syrup) ll Brozeet-SF(Ambroxol HCL-15mg+Terbutaline Sulphate-15mg+Guaiphenesin-50mg/5ml Syrup) llBROZEET-LS (Levosalbutamol-0.5mg +Ambroxl Hydrochloride BP-15 mg +Guaiphenesin IP-50 mg /5 ml Syrup) llFurobid-250/500 Tab ll Althrocin(Erythromycin Estolate Tablets) ll Al5zyme(Capsules/Liquid) Ph:- 0265-2280550,0265-2280880, 0265-3007000.

Tenasfree MedicareDONACT-5 TAB Donepezil 5mg lINSOFRESH-10 TAB Zolpidem 10 Mg l MIGACT-10 TAB. Flunarazine 10 Mg l MEDIP-INE- MD 5 TAB Olenzapin Md 5 Mg lMEDIPINE- MD 10 TAB Olenzapin Md 10 Mgl NILDEP-20 TAB Floxitin DT 20 Mg l PRO-

PELAR-F TAB Flunarazine 10 Mg Propranol40 Mg SR l PARKYDYL -2 Triphenihexydyl2mg l PARKYDYL PLUS 2 Triphenihexydyl2mg Resperidone 2 Mg l PARKYDYL PLUS3 Tripheninexydyl 2mg Resperidone 3 Mg lPARKIZINE-5 TAB Triphenihexydyl 2Triflupramazine 5 Mg l SEIZUMATE-50 TABTopiramat 50 Mg l TENCITA-C TABEscitalopram 10 Mg. Clonazepam0.5 Mg lTENCITA-EZ TAB. Escitalopram 10 MgEtizolam 0.5 Mg l TENCITA-EZ MINIEscitalopram 5 Mg Etizolam 0.5 Mg lTENCITA-FP TAB. Escitalopram 10 Mg.Flupentixol 0.5 Mg l TENSI FRESH-0.5 MDTAB Clonazepam 0.5 Mg l TENSI FRESH-0.25 MD TAB Clonazepam 0.25 Mg l TEN-COLINE AMP. Citicolin 1000 Mg Mob:-09736701313, 09882011313.

Ipca Laboratories Ltd.Vinicor-Am 25/2.5mg, 25/5mg, 50/5mg(Metoprolol Succinate ER + AmlodipineBesilate Tablets) ll Vinicor XL25mg/50mg/100mg (Metoprolol SuccinateER) ll Vinicor-D 25/6.25mg, 50/12.5mg(Metoprolol Succinate Extended-Release &Chlorthalidone Tablets) Mob:- 07412278000.

East India PharmaceuticalWork Ltd.

Tonoferon Drops (25mg Elemental iron /ml)l Tonoferon-SF (Ferrous Succinate 200mg+ Succinic Acid 210mg + Folic Acid 400mgper capsules) l Tonoferon (250mgElemental iron / 5ml) Pyrigesic IV(Paracetamol 1 g /100 ml) l Vitazyme(Fungal Diastase with Carminatives) lPyrigesic 1000 (Paracetamol 1g) l Trikase(Aciclvir Tablets 200mg/400mg/ 800mgCream) l Pyrigesic A (Aceclofenac 100mg+ Paracetamol 325 mg per film coatedtablets) l Keralin (Benzoic Acid 12% w/w +Salicylic Acid 6% w/w + HydrocortisoneAcetate 0.5% w/w) l Pyrigesic T (TramadolHCI 37.5 mg + Paracetamol 325mg per filmcoated tablet) l KAFBIN (Cough syrup) lPyrigesic Drops (Paracetamol 100mg/ml) lBactiv (Lactobacillus acidophilus -5 &Bifidobacterium -12 Capsules) l PyrigesicGEL l Livotone Capsule l ZOAMET Spray(Oxymetazoline Hydrochloride 0.05% w/w) lZOAMET-S (Saline Nasal Drops) l ACIDINGEL (Antacid & Antiflatulent OralSuspension) l Asmotone Plus l VitazymeDrops (Fungal Diastase with Carminatives) lVitazyme Capsule (Fungal Diastase(1:2000) 20mg + Lactic Acid Bacillus150x106 Spores per capsule) l D3 BABY(Vitamin D3 Oral Drops IU) l D3 BABY Plus(Vitamin D3 Oral Drops 800 IU) l Calron-D(Calcium with citamin D - Tablets) l LOCU-LA-TR Eye Drop (SodiumCarbixymethylcellulose 0.5% w/w) lZOAMET Paediatric Drops (OxymetazolineHydrochloride 0.025% w/v) l Hepnar lPyrigesic Tablet (Paracetamol 500mg) lPyrigesic 650 (Paracetamol 650mg) lPyrigesic DS Suspension (Paracetamol250mg / 5ml) l Pyrigesic Suspension(Paracetamol 125mg / 5ml) l Conflu(Fluconazole 150mg & 200mg Capsule) lCyclovarin Capsule (Non hormonalUterotrophic) Ph:- 011-23262150.

NANSOM Ltd.Paranan (Mefenamic Acid 50mg +Paracetamol 125mg / 5ml) l Codinan(Codeine Phosphate 10 Mg + CPM 4 mg) lEL D3 Sachet ( Cholicalciferol 60000 I.U.) lLivonan (An Ayurvedic Liver Preparation..) lDefna (Deflazacort 6mg / 5ml) l Aptinan(Cyproheptadine HCL & Tricholine Citrate) lProtinan (Protein Preparation Available asVanilla & Chocolate Flavour)

Mob:- 9810007165.

OAKNET Healthcare Ltd.Aceron-TC (Aceclofenac 100mg +Paracetamol 325mg + Trypsin Chymotrypsin(6:1) 75000 AU Tablets) l Aceron-MR 4/8(Aceclofenac 100mg + Paracetamol 325mg +Thiocolchicoside 4/8mg Tablets) l Aceron P(Aceclofenac 100mg + Paracetamol 325 mgTablets) l Densical 225/500 (Elemental CoralCalcium 225mg / 500mg, Vit. D3 500 IU(Elemental Magnesium 12.85mg in 225mgTablets) l Densical-CT (Elemental CoralCalcium 500mg + Calcitriol 0.25mcg + Zinc4mg Tablets) l Algibra (Rabeprazole 20mg) lAlgibra-D (Rabeprazole 20mg +Domperidone 30mg Capsules) l Menabol(Stanozolol 2mg Tablets) Mob:- 08043000400.

Product List

New Data Supports the Safety and Efficacy of GSK's Shingrix in preventing Shingles in AutologousHaematopoietic Stem Cell Transplant Patients

GlaxoSmithKline today announced that new data from a Phase III clinical study supports the safety and efficacy of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in preventing shingles(herpes zoster) when given to adults 18 years and above shortly after undergoing autologous haematopoietic stem cell transplant (auHSCT). Shingrix is a non-live, recombinant adjuvanted sub-unit vaccine given intramuscularly in two doses. The ZOE-HSCT study succeeded in its primary objective by demonstrating an efficacy of 68.17% [95%CI: 55.56 - 77.53] against shingles in sub-jects above 18 years of age after receiving an autologous haematopoietic stem cell transplant. In subjects aged 50 and above, the efficacy was similar, 67.34% [95% CI: 52.60 - 77.89]. The vac-cine reduced overall complications linked to shingles episodes by 77.76% [95% CI: 19.05% - 95.93%]. Vaccine efficacy for the prevention of post-herpetic neuralgia, a form of chronic nerve painand the most common complication associated with shingles, was 89.27% [95% CI: 22.54-99.76]. No safety issues related to the vaccine were detected during the study. "The immune systemsof these stem cell transplant recipients is substantially weakened compared to the general older adult populations studied in other Shingrix efficacy trials," Emmanuel Hanon, Senior Vice President

and Head of Vaccines R&D for GSK said. "This puts them at much higher risk for viral diseases like shingles and, at the same time, makes developing an effective vaccine to help protect themmore challenging." "Today's results, demonstrating the vaccine's ability to help prevent shingles and its complications with just two doses, may provide a much-needed benefit to these patientsconsidering the high incidence and burden of disease they face," he said. Shingrix is the first shingles vaccine to combine a non-live antigen, to trigger a targeted immune response, with a specif-ically designed adjuvant to generate a strong and sustained immune response. GSK is evaluating these results together with those of other Phase III studies in immune-compromised patient

populations. Allthese data will beshared and dis-cussed with regu-latory as well aspublic healthagencies with theobjective of bestinforming healthcare providers onthe use of Shingrixin those patientswith greatest med-ical need. Shingrixis now approved inCanada and USfor the preventionof herpes zoster inadults aged 50years and above.R e g u l a t o r yreviews are cur-rently underway inthe EuropeanUnion, Australiaand Japan.

GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangi-itis (EGPA) for adults in the US

GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangi-itis (EGPA), previously known as Churg-Strauss syndrome. GSK submitted a supplemental Biologics License Application (sBLA) for mepolizumab, an interleukin-5 (IL-5) antagonist, in June 2017.Eric Dube, Senior Vice President & Head, GSK Global Respiratory Franchise, said: "Following physician and patient experience with Nucala in severe eosinophilic asthma, we are thrilled that theFDA has expanded the use of this medicine to patients with EGPA, another eosinophil-driven disease, enabling GSK to make it available to patients. This approval follows the positive results of thelargest prospective treatment study conducted in EGPA to date, and now for the first time physicians have a targeted treatment option for this debilitating condition." Mepolizumab is not approved forthe treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus. The approval for EGPA is based on results from the pivotal, 52-week, Phase III MIRRA[1] study,conducted as a collaboration between GSK and the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health. The MIRRA study evaluated the efficacy and safe-ty of 300mg of mepolizumab administered subcutaneously every four weeks versus placebo as add-on therapy to standard of care (corticosteroids plus or minus immunosuppressants) in 136 patientswith relapsing and/or refractory EGPA: " both co-primary endpoints (accrued time in remission and proportion of patients achieving remission at both weeks 36 and 48) were statistically significant infavour of mepolizumab " all six secondary endpoints (investigating relapse, remission, and corticosteroid use) were met in favour of mepolizumab " the percentage of patients experiencing on-treat-ment adverse events was comparable between the two treatment groups (97% mepolizumab versus 94% placebo). Injection site reactions (e.g., pain, erythema, swelling) occurred at a rate of 15%in patients receiving mepolizumab compared with 13% in patients receiving placebo. Eighteen percent of patients receiving mepolizumab reported serious adverse events compared with 26% in theplacebo group, with the most frequently reported being asthma worsening/exacerbation (3% versus 6%). Dr. Peter A. Merkel, Chief, Division of Rheumatology at Perelman School of Medicine,University of Pennsylvania & MIRRA study site investigator said: "Patients suffering from EGPA too often face a frustrating journey from a delay in receiving a proper diagnosis to having few effectivetreatment options with an acceptable safety profile. Rheumatologists, immunologists, and pulmonologists have an important role in properly diagnosing and treating patients with EGPA. Today'sapproval of mepolizumab provides specialists with the ability to offer a targeted treatment to appropriate patients with this complex disease." Dr. Michael E. Wechsler, Professor of Medicine at NationalJewish Health in Denver, Colorado, US & Principal Investigator of the MIRRA study, said: "Patients with EGPA often suffer from recurrent relapses that place them at greater risk of permanent tissueand organ damage. Clinical data demonstrated that mepolizumab increased accrued time in remission, reduced the frequency of relapse and flares, and enabled patients to have their dose of corti-costeroid reduced compared to placebo in patients already receiving standard of care. These are key treatment goals and this approval is an important milestone both for treating physicians and forpatients." Nucala for treatment of EGPA in the US is available now. In recognition of the fact that US consumers are increasingly being asked by their insurers to take on more cost sharing, makingaffordability a concern for some patients, GSK has various patient assistance programmes available for those who qualify.

Happy BirthdayDOB NAME FIRM MOB CITY STATE01.01.81 MOHD .AMIL JI NATIONAL MEDICAL AGEANCY 9058275769 SAMBHAL UTTAR PRADESH01.01.75 SHRI ALOK NAUTIYAL JI APNA MEDICAL STORE 9719010008 DEHRADUN UTTRAKHAND01.01.61 SHRI ANIL GUPTA JI KAILASH MEDICALHALL 9416388393 JIND HARYANA01.01.73 SHRI ASHOK KUMAR SHARMA JI SRI SARKAR ENTERPRICES 9808569076 BADAUN UTTAR PRADESH02.01.76 SHRI ABHAY KUMAR GUPTA JI AMAN MEDICAL AGENCY 9839209711 VARANASI UTTAR PRADESH02.01.64 SHRI AJIT K.R. DESDMUKH JI SWAMI MEDICAL HALL 9835284763 BHOJPUR RAJASTHAN05.01.81 SHRI AJIT K.R. SINGH JI SHREE SHIVAM DURG AGENCY 9934929885 SAMASTIPUR BIHAR07.01.81 SHRI AMIT KUMAR JI S. PHARMA 9415974267 VARANASI UTTAR PRADESH09.01.64 SHRI AMEET GOYAL JI GOYAL PHARMA 9972209830 BIDAR KARNATAKA10.01.69 SHRI DR.ARVIND K.R. SINGH JI MEDICAL AGENCY 9336897407 KANNAUJ UTTAR PRADESH15.01.68 SHRI AKHILASH KUMAR SRIVASTAVA JI PURVANCHAL PHARMA 9450248591 JAUNPUR UTTAR PRADESH15.01.70 SHRI ASHWIN KUMAR JI PHARMA LINK 9431094446 PATNA BIHAR17.01.61 SHRI ABHAY N. BORAD JI SWAGAT MEDICAL STORE 9422859947 SATNA MAHARASHTRA18.01.54 SHARI ASHOK MEHRA JI PIONEER MEDICAL STORE 9837038302 MUSSORIE UTTRAKHAND19.01.80 SHRI AASHISH VIRMANI JI SUBHASH BRO.& MEDICAL STORE 9837187230 HARIDWAR UTTRAKHAND23.01.66 SHRI AJAY AGARWAL JI AJAY MEDICAL STORE 9452031869 CHITRKUT UTTAR PRADESH24.01.72 SHRI ASHOK DAWAR JI DADA DISTIRIBATORS 9855002800 LUDHNIANA PUNJAB30.01.70 SHRI AJEET KUMAR AGARWAL JI SAROUR SPECILITY 9219506076 DEHRADUN UTTRAKHAND

eeSSMMhhddyy nniiZZ..kk eehhffMM;;kk ggkkÅÅll ddhh rrjjiiQQ llss vvkkii llHHkkhh ddkkss ttUUeeffnnuu ddhh ggkkffnnZZdd ''kkqqHHkkddkkeeuukk;;ssaa

ookk;;qq ççnnww""kk..kk llss ccPPppkkssaa ddkkss ddkkSSuullhh cchheekkjjhh ddkk ggkkssrrkk ggSS [[kkrrjjkk;wfulsiQ dh ubZ fjiksVZ ds eqrkfcd] yxHkx 1-7 djksM+ cPps mu {ks=kksa esa jgrs gSa] tgka ok;q çnw"k.k varjjk"Vªh; lhek ls Ng xquk vf/d gksrk gS] tks laHkkfor :i ls muds efLr"d ds fodkl ds fy, orjukd gS D;ksafd os ,d ,slhgok esa lk¡l ysrs gSa tks muds LokLF; ds fy, gkfudkjd gS- bu cPpksa esa vf/dka'k la[;k nf{k.k ,f'k;k esa gS- nf{k.k ,f'k;k esa 12 yko ls vf/d cPps blls ihfM+r gSa- lcls nqon ;g gS fd çnw"k.k ls mUgsa thouHkj ds fy,LokLF; leL;k,a iSnk gks ldrh gSa- dbZ vè;;uksa ls irk pyk gS fd ok;q çnw"k.k 'okl laca/h dbZ jksxksa ls lh/s rkSj ij tqM+k gqvk gS] ftuesa fueksfu;k] czksadkbfVl vkSj vLFkek çeqo gSa- ;g cPpksa dh jksxksa ls yM+us dh {kerk dksHkh çHkkfor dj ldrk gS- ok;q çnw"k.k iQsiQM+s vkSj efLr"d ds fodkl vkSj laKkukRed fodkl dks Hkh çHkkfor dj ldrk gS- vxj bykt ugha djok;k tk, rks ok;q çnw"k.k ls lacaf/r dqN LokLF; laca/h tfVyrk,a iwjh ftanxh cuhjg ldrh gSa- chrs nkSj e